| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | COMP EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 ECM1 THBS2 THBS4 FBLN2 FBN2 LTBP2 AGRN FBN3 | 4.05e-18 | 188 | 103 | 18 | GO:0005201 |
| GeneOntologyMolecularFunction | calcium ion binding | COMP ENPP1 FAT3 EFEMP2 DLK1 VWCE LRP1B SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 NOTCH2NLB JAG1 SLIT3 LRP1 LRP2 LTBP2 LTBP3 ADGRE1 AGRN FBN3 NOTCH2 NOTCH3 NOTCH4 | 6.52e-16 | 749 | 103 | 27 | GO:0005509 |
| GeneOntologyMolecularFunction | structural molecule activity | COMP KRT83 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 ECM1 THBS2 THBS4 FBLN2 FBN2 JAG1 LTBP2 AGRN FBN3 OTOG | 4.38e-09 | 891 | 103 | 21 | GO:0005198 |
| GeneOntologyMolecularFunction | sulfur compound binding | MPO COMP ENPP1 EFEMP2 LAMC2 NELL2 THBS2 THBS4 SLIT3 LRP1 LTBP2 AGRN | 1.07e-07 | 323 | 103 | 12 | GO:1901681 |
| GeneOntologyMolecularFunction | glycosaminoglycan binding | MPO COMP EFEMP2 LAMC2 STAB1 NELL2 THBS2 THBS4 SLIT3 LTBP2 AGRN | 1.39e-07 | 268 | 103 | 11 | GO:0005539 |
| GeneOntologyMolecularFunction | extracellular matrix constituent conferring elasticity | 3.20e-07 | 12 | 103 | 4 | GO:0030023 | |
| GeneOntologyMolecularFunction | structural molecule activity conferring elasticity | 6.42e-07 | 14 | 103 | 4 | GO:0097493 | |
| GeneOntologyMolecularFunction | heparin binding | 6.71e-07 | 192 | 103 | 9 | GO:0008201 | |
| GeneOntologyMolecularFunction | low-density lipoprotein particle receptor activity | 1.16e-06 | 16 | 103 | 4 | GO:0005041 | |
| GeneOntologyMolecularFunction | lipoprotein particle receptor activity | 3.74e-06 | 21 | 103 | 4 | GO:0030228 | |
| GeneOntologyMolecularFunction | integrin binding | 3.44e-05 | 175 | 103 | 7 | GO:0005178 | |
| GeneOntologyMolecularFunction | glycosphingolipid binding | 3.67e-05 | 13 | 103 | 3 | GO:0043208 | |
| GeneOntologyMolecularFunction | extracellular matrix binding | 3.77e-05 | 73 | 103 | 5 | GO:0050840 | |
| GeneOntologyMolecularFunction | cargo receptor activity | 7.83e-05 | 85 | 103 | 5 | GO:0038024 | |
| GeneOntologyMolecularFunction | structural constituent of synapse-associated extracellular matrix | 7.88e-05 | 3 | 103 | 2 | GO:0150043 | |
| GeneOntologyMolecularFunction | signaling receptor inhibitor activity | 9.22e-05 | 46 | 103 | 4 | GO:0030547 | |
| GeneOntologyMolecularFunction | vitamin E binding | 1.57e-04 | 4 | 103 | 2 | GO:0008431 | |
| GeneOntologyMolecularFunction | growth factor binding | 1.58e-04 | 156 | 103 | 6 | GO:0019838 | |
| GeneOntologyMolecularFunction | transforming growth factor beta binding | 3.18e-04 | 26 | 103 | 3 | GO:0050431 | |
| GeneOntologyMolecularFunction | Notch binding | 3.56e-04 | 27 | 103 | 3 | GO:0005112 | |
| GeneOntologyMolecularFunction | scavenger receptor activity | 3.56e-04 | 27 | 103 | 3 | GO:0005044 | |
| GeneOntologyMolecularFunction | heparan sulfate proteoglycan binding | 4.42e-04 | 29 | 103 | 3 | GO:0043395 | |
| GeneOntologyMolecularFunction | receptor antagonist activity | 5.93e-04 | 32 | 103 | 3 | GO:0048019 | |
| GeneOntologyMolecularFunction | sphingolipid binding | 7.10e-04 | 34 | 103 | 3 | GO:0046625 | |
| GeneOntologyMolecularFunction | fibronectin binding | 9.86e-04 | 38 | 103 | 3 | GO:0001968 | |
| GeneOntologyMolecularFunction | vitamin binding | 1.48e-03 | 161 | 103 | 5 | GO:0019842 | |
| GeneOntologyMolecularFunction | glycolipid binding | 2.07e-03 | 49 | 103 | 3 | GO:0051861 | |
| GeneOntologyMolecularFunction | proteoglycan binding | 2.32e-03 | 51 | 103 | 3 | GO:0043394 | |
| GeneOntologyMolecularFunction | polyubiquitin modification-dependent protein binding | 3.51e-03 | 59 | 103 | 3 | GO:0031593 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | 3.81e-03 | 599 | 103 | 9 | GO:0050839 | |
| GeneOntologyMolecularFunction | signaling receptor regulator activity | 4.57e-03 | 616 | 103 | 9 | GO:0030545 | |
| GeneOntologyBiologicalProcess | axon guidance | LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 SLIT3 LRP1 LRP2 AGRN NOTCH2 NOTCH3 | 1.22e-11 | 285 | 103 | 15 | GO:0007411 |
| GeneOntologyBiologicalProcess | neuron projection guidance | LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 SLIT3 LRP1 LRP2 AGRN NOTCH2 NOTCH3 | 1.28e-11 | 286 | 103 | 15 | GO:0097485 |
| GeneOntologyBiologicalProcess | positive regulation of integrin-mediated signaling pathway | 3.89e-11 | 14 | 103 | 6 | GO:2001046 | |
| GeneOntologyBiologicalProcess | animal organ morphogenesis | COMP ENPP1 ADAM15 FAT3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 AHDC1 STAT6 GRXCR2 FBN2 JAG1 SLIT3 LRP2 LRP5 TRPM1 LTBP3 USH2A MEGF11 NOTCH2 | 4.37e-10 | 1269 | 103 | 26 | GO:0009887 |
| GeneOntologyBiologicalProcess | regulation of integrin-mediated signaling pathway | 1.26e-09 | 23 | 103 | 6 | GO:2001044 | |
| GeneOntologyBiologicalProcess | regulation of basement membrane organization | 1.27e-09 | 11 | 103 | 5 | GO:0110011 | |
| GeneOntologyBiologicalProcess | axon development | ENPP1 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 SLIT3 LRP1 LRP2 AGRN NOTCH2 PLXNB3 NOTCH3 | 1.86e-08 | 642 | 103 | 17 | GO:0061564 |
| GeneOntologyBiologicalProcess | axonogenesis | LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 SLIT3 LRP1 LRP2 AGRN NOTCH2 PLXNB3 NOTCH3 | 2.07e-08 | 566 | 103 | 16 | GO:0007409 |
| GeneOntologyBiologicalProcess | cell morphogenesis involved in neuron differentiation | FAT3 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 GRXCR2 SLIT3 LRP1 LRP2 AGRN NOTCH2 PLXNB3 NOTCH3 | 2.93e-08 | 748 | 103 | 18 | GO:0048667 |
| GeneOntologyBiologicalProcess | positive regulation of muscle cell differentiation | 5.91e-08 | 106 | 103 | 8 | GO:0051149 | |
| GeneOntologyBiologicalProcess | basement membrane organization | 7.03e-08 | 43 | 103 | 6 | GO:0071711 | |
| GeneOntologyBiologicalProcess | cell morphogenesis | ENPP1 FAT3 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 ST14 NELL2 GRXCR2 THBS4 SLIT3 LRP1 LRP2 AGRN NOTCH2 PLXNB3 NOTCH3 NOTCH4 | 8.27e-08 | 1194 | 103 | 22 | GO:0000902 |
| GeneOntologyBiologicalProcess | regulation of cell adhesion | PCSK5 ERBB3 ADAM19 FSTL3 ADAM15 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 ZBTB1 TYK2 FBLN2 JAG1 LRP1 PLXNB3 NOTCH4 | 1.44e-07 | 927 | 103 | 19 | GO:0030155 |
| GeneOntologyBiologicalProcess | integrin-mediated signaling pathway | 2.00e-07 | 124 | 103 | 8 | GO:0007229 | |
| GeneOntologyBiologicalProcess | regulation of extracellular matrix organization | 2.08e-07 | 84 | 103 | 7 | GO:1903053 | |
| GeneOntologyBiologicalProcess | neuron projection development | ENPP1 FAT3 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 GRXCR2 THBS4 LINGO1 SLIT3 LRP1 LRP2 AGRN NOTCH2 PLXNB3 NOTCH3 OTOG | 2.95e-07 | 1285 | 103 | 22 | GO:0031175 |
| GeneOntologyBiologicalProcess | artery development | 3.44e-07 | 133 | 103 | 8 | GO:0060840 | |
| GeneOntologyBiologicalProcess | artery morphogenesis | 3.90e-07 | 92 | 103 | 7 | GO:0048844 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTSL1 COMP ADAM15 EFEMP2 LAMA1 LAMA2 LAMB1 LAMB2 LAMB3 LAMC1 ADAMTS7 LRP1 | 4.01e-07 | 377 | 103 | 12 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTSL1 COMP ADAM15 EFEMP2 LAMA1 LAMA2 LAMB1 LAMB2 LAMB3 LAMC1 ADAMTS7 LRP1 | 4.12e-07 | 378 | 103 | 12 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTSL1 COMP ADAM15 EFEMP2 LAMA1 LAMA2 LAMB1 LAMB2 LAMB3 LAMC1 ADAMTS7 LRP1 | 4.24e-07 | 379 | 103 | 12 | GO:0045229 |
| GeneOntologyBiologicalProcess | neuron projection morphogenesis | LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 THBS4 SLIT3 LRP1 LRP2 AGRN NOTCH2 PLXNB3 NOTCH3 | 4.48e-07 | 802 | 103 | 17 | GO:0048812 |
| GeneOntologyBiologicalProcess | plasma membrane bounded cell projection morphogenesis | LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 THBS4 SLIT3 LRP1 LRP2 AGRN NOTCH2 PLXNB3 NOTCH3 | 6.00e-07 | 819 | 103 | 17 | GO:0120039 |
| GeneOntologyBiologicalProcess | neuron development | ENPP1 FAT3 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 GRXCR2 THBS4 LINGO1 SLIT3 LRP1 LRP2 TRPM1 AGRN NOTCH2 PLXNB3 NOTCH3 OTOG | 6.74e-07 | 1463 | 103 | 23 | GO:0048666 |
| GeneOntologyBiologicalProcess | cell projection morphogenesis | LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 NELL2 THBS4 SLIT3 LRP1 LRP2 AGRN NOTCH2 PLXNB3 NOTCH3 | 6.75e-07 | 826 | 103 | 17 | GO:0048858 |
| GeneOntologyBiologicalProcess | cell-substrate adhesion | PCSK5 ADAM15 EFEMP2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 SVEP1 FBLN2 JAG1 LRP1 | 9.71e-07 | 410 | 103 | 12 | GO:0031589 |
| GeneOntologyBiologicalProcess | vasculature development | PCSK5 COMP ENPP1 ADAM15 EFEMP2 LAMA1 ECM1 SVEP1 STAB1 THBS2 JAG1 LRP1 LRP2 LRP5 C6 NOTCH2 NOTCH3 NOTCH4 | 1.33e-06 | 969 | 103 | 18 | GO:0001944 |
| GeneOntologyBiologicalProcess | transforming growth factor beta receptor superfamily signaling pathway | COMP FSTL3 KCP FBN2 WFIKKN2 VWC2L LRP1 LRP2 LTBP2 LTBP3 DKK3 NOTCH2 | 2.28e-06 | 445 | 103 | 12 | GO:0141091 |
| GeneOntologyBiologicalProcess | blood vessel morphogenesis | COMP ENPP1 ADAM15 EFEMP2 LAMA1 ECM1 STAB1 THBS2 JAG1 LRP1 LRP2 LRP5 C6 NOTCH2 NOTCH3 NOTCH4 | 2.84e-06 | 817 | 103 | 16 | GO:0048514 |
| GeneOntologyBiologicalProcess | aorta development | 2.98e-06 | 80 | 103 | 6 | GO:0035904 | |
| GeneOntologyBiologicalProcess | blood vessel development | PCSK5 COMP ENPP1 ADAM15 EFEMP2 LAMA1 ECM1 STAB1 THBS2 JAG1 LRP1 LRP2 LRP5 C6 NOTCH2 NOTCH3 NOTCH4 | 3.34e-06 | 929 | 103 | 17 | GO:0001568 |
| GeneOntologyBiologicalProcess | cell surface receptor protein serine/threonine kinase signaling pathway | COMP FSTL3 KCP FBN2 WFIKKN2 VWC2L LRP1 LRP2 LTBP2 LTBP3 DKK3 NOTCH2 | 5.16e-06 | 482 | 103 | 12 | GO:0007178 |
| GeneOntologyBiologicalProcess | enzyme-linked receptor protein signaling pathway | ERBB3 COMP FSTL3 ENPP1 INSRR KCP SVEP1 STAT6 TYK2 FBN2 WFIKKN2 VWC2L LRP1 LRP2 LTBP2 LTBP3 AGRN DKK3 NOTCH2 | 5.72e-06 | 1186 | 103 | 19 | GO:0007167 |
| GeneOntologyBiologicalProcess | regulation of muscle cell differentiation | 7.08e-06 | 199 | 103 | 8 | GO:0051147 | |
| GeneOntologyBiologicalProcess | circulatory system development | PCSK5 ERBB3 ADAM19 COMP ENPP1 ADAM15 EFEMP2 LAMA1 ECM1 SVEP1 STAB1 THBS2 JAG1 SLIT3 LRP1 LRP2 LRP5 C6 NOTCH2 NOTCH3 NOTCH4 | 7.49e-06 | 1442 | 103 | 21 | GO:0072359 |
| GeneOntologyBiologicalProcess | tube morphogenesis | COMP ENPP1 ADAM15 EFEMP2 LAMA1 LAMA5 ECM1 ST14 STAB1 THBS2 JAG1 LRP1 LRP2 LRP5 C6 NOTCH2 NOTCH3 NOTCH4 | 1.06e-05 | 1125 | 103 | 18 | GO:0035239 |
| GeneOntologyBiologicalProcess | positive regulation of cell differentiation | EFEMP2 LAMA1 LAMA2 LAMB1 LAMB2 LAMC1 DLK1 ZBTB1 FBN2 JAG1 VWC2L LRP1 LRP2 LRP5 LTBP3 NOTCH2 PLXNB3 NOTCH4 | 1.29e-05 | 1141 | 103 | 18 | GO:0045597 |
| GeneOntologyBiologicalProcess | glomerular epithelial cell development | 1.41e-05 | 10 | 103 | 3 | GO:0072310 | |
| GeneOntologyBiologicalProcess | podocyte development | 1.41e-05 | 10 | 103 | 3 | GO:0072015 | |
| GeneOntologyBiologicalProcess | tube development | PCSK5 COMP ENPP1 ADAM15 EFEMP2 LAMA1 LAMA5 ECM1 ST14 STAB1 THBS2 JAG1 LRP1 LRP2 LRP5 LTBP3 C6 NOTCH2 NOTCH3 NOTCH4 | 1.74e-05 | 1402 | 103 | 20 | GO:0035295 |
| GeneOntologyBiologicalProcess | epidermis development | KRT83 LAMA5 LAMB3 LAMC1 LAMC2 KEAP1 ST14 SVEP1 GRXCR2 JAG1 USH2A | 1.94e-05 | 461 | 103 | 11 | GO:0008544 |
| GeneOntologyBiologicalProcess | cell-cell adhesion | ADAM19 ZAN COMP FSTL3 FAT3 LAMB1 ZBTB1 SVEP1 TYK2 THBS4 LRFN4 JAG1 LRP5 MEGF11 PLXNB3 NOTCH4 PEAR1 | 2.30e-05 | 1077 | 103 | 17 | GO:0098609 |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell-matrix adhesion | 2.47e-05 | 2 | 103 | 2 | GO:1905609 | |
| GeneOntologyBiologicalProcess | basement membrane assembly | 2.57e-05 | 12 | 103 | 3 | GO:0070831 | |
| GeneOntologyBiologicalProcess | positive regulation of cell adhesion | PCSK5 ADAM19 FSTL3 EFEMP2 LAMA1 LAMA2 LAMB1 LAMB2 LAMC1 ZBTB1 TYK2 FBLN2 | 3.20e-05 | 579 | 103 | 12 | GO:0045785 |
| GeneOntologyBiologicalProcess | tissue remodeling | 5.12e-05 | 262 | 103 | 8 | GO:0048771 | |
| GeneOntologyBiologicalProcess | aorta morphogenesis | 5.15e-05 | 41 | 103 | 4 | GO:0035909 | |
| GeneOntologyBiologicalProcess | skeletal system development | PCSK5 COMP ENPP1 LAMA5 DLK1 ECM1 FBN2 ADAMTS7 WFIKKN2 LRP5 LTBP3 NOTCH2 | 5.72e-05 | 615 | 103 | 12 | GO:0001501 |
| GeneOntologyBiologicalProcess | cardiac septum development | 5.73e-05 | 134 | 103 | 6 | GO:0003279 | |
| GeneOntologyBiologicalProcess | regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 6.09e-05 | 347 | 103 | 9 | GO:0090092 | |
| GeneOntologyBiologicalProcess | cellular response to growth factor stimulus | COMP FSTL3 ENPP1 KCP FBN2 ADAMTS7 WFIKKN2 VWC2L LRP1 LRP2 LTBP2 LTBP3 DKK3 NOTCH2 | 8.35e-05 | 850 | 103 | 14 | GO:0071363 |
| GeneOntologyBiologicalProcess | Notch signaling pathway | 8.90e-05 | 210 | 103 | 7 | GO:0007219 | |
| GeneOntologyBiologicalProcess | muscle structure development | ERBB3 COMP EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 JAG1 WFIKKN2 LRP2 NOTCH2 NOTCH4 | 9.22e-05 | 858 | 103 | 14 | GO:0061061 |
| GeneOntologyBiologicalProcess | regulation of bone mineralization | 9.32e-05 | 91 | 103 | 5 | GO:0030500 | |
| GeneOntologyBiologicalProcess | regulation of ossification | 9.58e-05 | 147 | 103 | 6 | GO:0030278 | |
| GeneOntologyBiologicalProcess | response to BMP | 1.03e-04 | 215 | 103 | 7 | GO:0071772 | |
| GeneOntologyBiologicalProcess | cellular response to BMP stimulus | 1.03e-04 | 215 | 103 | 7 | GO:0071773 | |
| GeneOntologyBiologicalProcess | bone mineralization | 1.03e-04 | 149 | 103 | 6 | GO:0030282 | |
| GeneOntologyBiologicalProcess | adaptive immune response based on somatic recombination of immune receptors built from immunoglobulin superfamily domains | 1.06e-04 | 462 | 103 | 10 | GO:0002460 | |
| GeneOntologyBiologicalProcess | negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway | 1.12e-04 | 218 | 103 | 7 | GO:0090101 | |
| GeneOntologyBiologicalProcess | negative regulation of ossification | 1.13e-04 | 50 | 103 | 4 | GO:0030279 | |
| GeneOntologyBiologicalProcess | response to growth factor | COMP FSTL3 ENPP1 KCP FBN2 ADAMTS7 WFIKKN2 VWC2L LRP1 LRP2 LTBP2 LTBP3 DKK3 NOTCH2 | 1.25e-04 | 883 | 103 | 14 | GO:0070848 |
| GeneOntologyBiologicalProcess | podocyte differentiation | 1.74e-04 | 22 | 103 | 3 | GO:0072112 | |
| GeneOntologyBiologicalProcess | glomerular epithelial cell differentiation | 1.74e-04 | 22 | 103 | 3 | GO:0072311 | |
| GeneOntologyBiologicalProcess | renal filtration cell differentiation | 1.74e-04 | 22 | 103 | 3 | GO:0061318 | |
| GeneOntologyBiologicalProcess | immunoglobulin mediated immune response | 1.79e-04 | 235 | 103 | 7 | GO:0016064 | |
| GeneOntologyBiologicalProcess | negative regulation of bone mineralization | 1.99e-04 | 23 | 103 | 3 | GO:0030502 | |
| GeneOntologyBiologicalProcess | glomerular epithelium development | 1.99e-04 | 23 | 103 | 3 | GO:0072010 | |
| GeneOntologyBiologicalProcess | extracellular matrix assembly | 2.16e-04 | 59 | 103 | 4 | GO:0085029 | |
| GeneOntologyBiologicalProcess | substrate adhesion-dependent cell spreading | 2.18e-04 | 109 | 103 | 5 | GO:0034446 | |
| GeneOntologyBiologicalProcess | camera-type eye morphogenesis | 2.19e-04 | 171 | 103 | 6 | GO:0048593 | |
| GeneOntologyBiologicalProcess | regulation of cellular response to growth factor stimulus | 2.22e-04 | 412 | 103 | 9 | GO:0090287 | |
| GeneOntologyBiologicalProcess | B cell mediated immunity | 2.25e-04 | 244 | 103 | 7 | GO:0019724 | |
| GeneOntologyBiologicalProcess | positive regulation of lysosomal protein catabolic process | 2.45e-04 | 5 | 103 | 2 | GO:1905167 | |
| GeneOntologyBiologicalProcess | regulation of smooth muscle cell-matrix adhesion | 2.45e-04 | 5 | 103 | 2 | GO:2000097 | |
| GeneOntologyBiologicalProcess | chemoattraction of axon | 2.45e-04 | 5 | 103 | 2 | GO:0061642 | |
| GeneOntologyBiologicalProcess | axon extension involved in regeneration | 2.45e-04 | 5 | 103 | 2 | GO:0048677 | |
| GeneOntologyBiologicalProcess | embryo development | PCSK5 PLAC1 ENPP1 LAMA1 LAMA2 LAMA5 DLK1 KEAP1 LRP1B AHDC1 ST14 GRXCR2 FBN2 JAG1 LRP2 LRP5 C6 NOTCH2 | 2.52e-04 | 1437 | 103 | 18 | GO:0009790 |
| GeneOntologyBiologicalProcess | regulation of biomineral tissue development | 2.69e-04 | 114 | 103 | 5 | GO:0070167 | |
| GeneOntologyBiologicalProcess | sensory organ development | ENPP1 FAT3 LAMA1 LAMB2 GRXCR2 JAG1 LRP5 TRPM1 USH2A MEGF11 NOTCH2 OTOG | 2.83e-04 | 730 | 103 | 12 | GO:0007423 |
| GeneOntologyBiologicalProcess | sensory organ morphogenesis | 3.25e-04 | 343 | 103 | 8 | GO:0090596 | |
| GeneOntologyBiologicalProcess | muscle cell differentiation | COMP EFEMP2 LAMA1 LAMA2 LAMB1 LAMB2 LAMC1 WFIKKN2 NOTCH2 NOTCH4 | 3.25e-04 | 531 | 103 | 10 | GO:0042692 |
| GeneOntologyBiologicalProcess | gliogenesis | 3.32e-04 | 435 | 103 | 9 | GO:0042063 | |
| GeneOntologyBiologicalProcess | positive regulation of smooth muscle cell differentiation | 3.62e-04 | 28 | 103 | 3 | GO:0051152 | |
| GeneOntologyBiologicalProcess | tissue morphogenesis | ENPP1 EFEMP2 LAMA1 LAMA5 LAMC1 AHDC1 ST14 JAG1 LRP2 LRP5 NOTCH2 NOTCH4 | 3.62e-04 | 750 | 103 | 12 | GO:0048729 |
| GeneOntologyBiologicalProcess | bone development | 3.62e-04 | 264 | 103 | 7 | GO:0060348 | |
| GeneOntologyBiologicalProcess | glomerulus vasculature morphogenesis | 3.66e-04 | 6 | 103 | 2 | GO:0072103 | |
| GeneOntologyBiologicalProcess | glomerular capillary formation | 3.66e-04 | 6 | 103 | 2 | GO:0072104 | |
| GeneOntologyBiologicalProcess | ciliary body morphogenesis | 3.66e-04 | 6 | 103 | 2 | GO:0061073 | |
| GeneOntologyBiologicalProcess | pulmonary artery morphogenesis | 3.66e-04 | 6 | 103 | 2 | GO:0061156 | |
| GeneOntologyBiologicalProcess | sprouting of injured axon | 3.66e-04 | 6 | 103 | 2 | GO:0048682 | |
| GeneOntologyBiologicalProcess | retinal blood vessel morphogenesis | 3.66e-04 | 6 | 103 | 2 | GO:0061304 | |
| GeneOntologyBiologicalProcess | lymphocyte mediated immunity | 4.17e-04 | 449 | 103 | 9 | GO:0002449 | |
| GeneOntologyBiologicalProcess | bone remodeling | 4.42e-04 | 127 | 103 | 5 | GO:0046849 | |
| GeneOntologyBiologicalProcess | BMP signaling pathway | 4.67e-04 | 197 | 103 | 6 | GO:0030509 | |
| GeneOntologyBiologicalProcess | ossification | 5.07e-04 | 562 | 103 | 10 | GO:0001503 | |
| GeneOntologyBiologicalProcess | regulation of BMP signaling pathway | 5.09e-04 | 131 | 103 | 5 | GO:0030510 | |
| GeneOntologyBiologicalProcess | renal system vasculature morphogenesis | 5.10e-04 | 7 | 103 | 2 | GO:0061438 | |
| GeneOntologyBiologicalProcess | kidney vasculature morphogenesis | 5.10e-04 | 7 | 103 | 2 | GO:0061439 | |
| GeneOntologyBiologicalProcess | positive regulation of protein catabolic process in the vacuole | 5.10e-04 | 7 | 103 | 2 | GO:1904352 | |
| GeneOntologyCellularComponent | extracellular matrix | LAMB4 ADAMTSL1 ADAM19 ZAN COMP EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 ECM1 SVEP1 THBS2 THBS4 FBLN2 FBN2 LINGO1 PLXDC2 ADAMTS7 LTBP2 LTBP3 USH2A AGRN FBN3 OTOG | 5.27e-20 | 656 | 103 | 29 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | LAMB4 ADAMTSL1 ADAM19 ZAN COMP EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 ECM1 SVEP1 THBS2 THBS4 FBLN2 FBN2 LINGO1 PLXDC2 ADAMTS7 LTBP2 LTBP3 USH2A AGRN FBN3 OTOG | 5.72e-20 | 658 | 103 | 29 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | LAMB4 ADAMTSL1 ADAM19 COMP EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 ECM1 THBS2 THBS4 FBLN2 FBN2 PLXDC2 LTBP2 LTBP3 USH2A AGRN | 9.97e-16 | 530 | 103 | 23 | GO:0062023 |
| GeneOntologyCellularComponent | basement membrane | LAMB4 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 THBS2 THBS4 USH2A AGRN | 1.10e-15 | 122 | 103 | 14 | GO:0005604 |
| GeneOntologyCellularComponent | laminin complex | 6.79e-15 | 10 | 103 | 7 | GO:0043256 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.55e-08 | 17 | 103 | 5 | GO:0098637 | |
| GeneOntologyCellularComponent | laminin-10 complex | 1.16e-07 | 3 | 103 | 3 | GO:0043259 | |
| GeneOntologyCellularComponent | laminin-11 complex | 1.16e-07 | 3 | 103 | 3 | GO:0043260 | |
| GeneOntologyCellularComponent | laminin-1 complex | 1.16e-07 | 3 | 103 | 3 | GO:0005606 | |
| GeneOntologyCellularComponent | laminin-5 complex | 4.63e-07 | 4 | 103 | 3 | GO:0005610 | |
| GeneOntologyCellularComponent | synaptic cleft | 5.60e-07 | 33 | 103 | 5 | GO:0043083 | |
| GeneOntologyCellularComponent | cell surface | TNFRSF9 ADAM19 ENPP1 ADAM15 DLK1 VWDE TLR8 ST14 LRFN4 ADAMTS7 GJD3 LRP1 LRP2 ADGRE1 AGRN NOTCH2 PLXNB3 NOTCH3 NOTCH4 | 1.82e-06 | 1111 | 103 | 19 | GO:0009986 |
| GeneOntologyCellularComponent | protein complex involved in cell adhesion | 1.07e-05 | 59 | 103 | 5 | GO:0098636 | |
| GeneOntologyCellularComponent | laminin-2 complex | 2.40e-05 | 2 | 103 | 2 | GO:0005607 | |
| GeneOntologyCellularComponent | microfibril | 3.21e-05 | 13 | 103 | 3 | GO:0001527 | |
| GeneOntologyCellularComponent | laminin-3 complex | 7.19e-05 | 3 | 103 | 2 | GO:0005608 | |
| GeneOntologyCellularComponent | receptor complex | ERBB3 INSRR LRP1B TYK2 VWC2L LRP1 LRP2 LRP5 NOTCH2 PLXNB3 NOTCH3 | 1.38e-04 | 581 | 103 | 11 | GO:0043235 |
| GeneOntologyCellularComponent | neuromuscular junction | 2.33e-04 | 112 | 103 | 5 | GO:0031594 | |
| GeneOntologyCellularComponent | membrane attack complex | 4.97e-04 | 7 | 103 | 2 | GO:0005579 | |
| GeneOntologyCellularComponent | endoplasmic reticulum lumen | 1.29e-03 | 332 | 103 | 7 | GO:0005788 | |
| GeneOntologyCellularComponent | axonal growth cone | 1.42e-03 | 45 | 103 | 3 | GO:0044295 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 4.15e-03 | 519 | 103 | 8 | GO:0009897 | |
| HumanPheno | Myopia | ERBB3 ADAMTSL1 ENPP1 LAMA1 LAMB2 AHDC1 FBN2 JAG1 WDR35 LRP2 LRP5 CHD6 TRPM1 LTBP2 USH2A VARS1 NOTCH2 | 3.71e-07 | 447 | 49 | 17 | HP:0000545 |
| MousePheno | abnormal epidermal-dermal junction morphology | 8.72e-07 | 12 | 93 | 4 | MP:0011159 | |
| MousePheno | abnormal tendon morphology | 1.73e-06 | 31 | 93 | 5 | MP:0005503 | |
| MousePheno | abnormal retina inner limiting membrane morphology | 1.56e-05 | 8 | 93 | 3 | MP:0010235 | |
| MousePheno | dermal-epidermal separation | 2.33e-05 | 9 | 93 | 3 | MP:0011160 | |
| MousePheno | abnormal blood vessel morphology | MPO PCSK5 ADAM19 ENPP1 ADAM15 EFEMP2 LAMA1 LAMA5 LAMC1 DLK1 ZFC3H1 AHDC1 THBS2 THBS4 ADAMTS7 PRICKLE3 FAM161A JAG1 SLIT3 LRP2 LRP5 NOTCH2 NOTCH3 NOTCH4 | 2.37e-05 | 1472 | 93 | 24 | MP:0001614 |
| MousePheno | abnormal skeletal muscle morphology | ADAM19 COMP FAT3 EFEMP2 LAMA2 LAMC1 FBN2 WFIKKN2 SLIT3 WDR35 LRP1 AGRN NOTCH3 | 3.00e-05 | 508 | 93 | 13 | MP:0000759 |
| MousePheno | diaphragmatic hernia | 3.84e-05 | 29 | 93 | 4 | MP:0003924 | |
| MousePheno | abnormal hypaxial muscle morphology | 4.21e-05 | 141 | 93 | 7 | MP:0003358 | |
| MousePheno | aneurysm | 8.21e-05 | 35 | 93 | 4 | MP:0003279 | |
| MousePheno | abnormal muscle morphology | MPO ERBB3 ADAM19 COMP ENPP1 FAT3 EFEMP2 LAMA2 LAMC1 THBS2 FBN2 WFIKKN2 SLIT3 WDR35 LRP1 LRP2 AGRN NOTCH2 NOTCH3 | 1.02e-04 | 1106 | 93 | 19 | MP:0002108 |
| MousePheno | abnormal basement membrane morphology | 1.40e-04 | 40 | 93 | 4 | MP:0004272 | |
| MousePheno | abnormal diaphragm morphology | 1.68e-04 | 78 | 93 | 5 | MP:0002279 | |
| MousePheno | acanthosis | 1.86e-04 | 43 | 93 | 4 | MP:0001874 | |
| MousePheno | limbs/digits/tail phenotype | PCSK5 COMP ENPP1 EFEMP2 LAMA5 LAMB1 LAMC1 LAMC2 ST14 SVEP1 THBS2 FBN2 AFM WFIKKN2 WDR35 LRP1 LRP2 LRP5 AGRN NOTCH2 | 1.88e-04 | 1258 | 93 | 20 | MP:0005371 |
| MousePheno | abnormal abdominal wall morphology | 2.13e-04 | 82 | 93 | 5 | MP:0003257 | |
| MousePheno | epidermis stratum spinosum hyperplasia | 2.22e-04 | 45 | 93 | 4 | MP:0009611 | |
| MousePheno | skin detachment | 2.60e-04 | 4 | 93 | 2 | MP:0009827 | |
| MousePheno | osteoarthritis | 3.48e-04 | 21 | 93 | 3 | MP:0003560 | |
| MousePheno | abnormal limb morphology | PCSK5 COMP ENPP1 EFEMP2 LAMA5 LAMC1 LAMC2 ST14 SVEP1 FBN2 AFM WFIKKN2 WDR35 LRP1 LRP5 AGRN NOTCH2 | 3.93e-04 | 1028 | 93 | 17 | MP:0002109 |
| MousePheno | abnormal joint physiology | 4.08e-04 | 145 | 93 | 6 | MP:0031169 | |
| MousePheno | paresis | 4.19e-04 | 53 | 93 | 4 | MP:0000754 | |
| MousePheno | omphalocele | 4.19e-04 | 53 | 93 | 4 | MP:0003052 | |
| MousePheno | absent kidney | 4.19e-04 | 53 | 93 | 4 | MP:0000520 | |
| MousePheno | abnormal eye vasculature morphology | ADAM15 LAMA1 ZFC3H1 THBS4 PRICKLE3 FAM161A LRP5 NOTCH2 NOTCH3 NOTCH4 | 4.28e-04 | 415 | 93 | 10 | MP:0031346 |
| MousePheno | kidney microaneurysm | 4.32e-04 | 5 | 93 | 2 | MP:0010451 | |
| MousePheno | myopathy | 4.50e-04 | 54 | 93 | 4 | MP:0000751 | |
| Domain | EGF_1 | HGFAC LAMB4 ADAM19 ZAN COMP ADAM15 FAT3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 DLK1 VWCE LRP1B VWDE SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 LTBP3 C6 C8A ADGRE1 USH2A AGRN MEGF11 FBN3 NOTCH2 NOTCH3 NOTCH4 PEAR1 | 6.66e-57 | 255 | 104 | 45 | PS00022 |
| Domain | EGF-like_dom | PCSK5 HGFAC ADAM19 ZAN COMP ADAM15 FAT3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 DLK1 VWCE LRP1B VWDE SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 LTBP3 C6 C8A ADGRE1 AGRN MEGF11 FBN3 NOTCH2 NOTCH3 NOTCH4 OTOG PEAR1 | 1.40e-55 | 249 | 104 | 44 | IPR000742 |
| Domain | EGF-like_CS | HGFAC LAMB4 ADAM19 ZAN COMP ADAM15 FAT3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 DLK1 VWCE LRP1B VWDE SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 LTBP3 C6 C8A ADGRE1 AGRN MEGF11 FBN3 NOTCH2 NOTCH3 NOTCH4 PEAR1 | 1.31e-54 | 261 | 104 | 44 | IPR013032 |
| Domain | EGF_2 | HGFAC LAMB4 ADAM19 ZAN COMP ADAM15 FAT3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 DLK1 VWCE LRP1B VWDE SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 LTBP3 C6 C8A ADGRE1 AGRN MEGF11 FBN3 NOTCH2 NOTCH3 NOTCH4 PEAR1 | 2.68e-54 | 265 | 104 | 44 | PS01186 |
| Domain | EGF | PCSK5 HGFAC ZAN COMP ADAM15 FAT3 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 DLK1 VWCE LRP1B VWDE SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 LTBP3 ADGRE1 AGRN MEGF11 FBN3 NOTCH2 NOTCH3 NOTCH4 PEAR1 | 1.55e-49 | 235 | 104 | 40 | SM00181 |
| Domain | Growth_fac_rcpt_ | PCSK5 ERBB3 TNFRSF9 COMP KRT83 EFEMP2 LAMA1 INSRR LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 VWCE LRP1B SVEP1 STAB1 NELL2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LTBP2 LTBP3 C8A ADGRE1 FBN3 NOTCH2 NOTCH3 NOTCH4 | 6.22e-44 | 156 | 104 | 33 | IPR009030 |
| Domain | EGF_3 | HGFAC ADAM19 ZAN COMP ADAM15 FAT3 EFEMP2 DLK1 VWCE LRP1B VWDE SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 LTBP3 C6 C8A ADGRE1 AGRN MEGF11 FBN3 NOTCH2 NOTCH3 NOTCH4 OTOG PEAR1 | 1.31e-42 | 235 | 104 | 36 | PS50026 |
| Domain | EGF-like_Ca-bd_dom | COMP FAT3 EFEMP2 DLK1 VWCE LRP1B SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 LTBP3 ADGRE1 AGRN FBN3 NOTCH2 NOTCH3 NOTCH4 | 2.18e-34 | 124 | 104 | 26 | IPR001881 |
| Domain | EGF_CA | COMP FAT3 EFEMP2 DLK1 VWCE LRP1B SVEP1 STAB1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LTBP2 LTBP3 ADGRE1 AGRN FBN3 NOTCH2 NOTCH3 NOTCH4 | 8.59e-33 | 122 | 104 | 25 | SM00179 |
| Domain | EGF_CA | COMP FAT3 EFEMP2 VWCE LRP1B SVEP1 NELL2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 LTBP3 ADGRE1 FBN3 NOTCH2 NOTCH3 NOTCH4 | 9.74e-30 | 99 | 104 | 22 | PS01187 |
| Domain | EGF_CA | COMP FAT3 EFEMP2 VWCE LRP1B SVEP1 NELL2 THBS2 THBS4 FBLN2 FBN2 JAG1 LRP1 LRP2 LTBP2 LTBP3 ADGRE1 FBN3 NOTCH2 NOTCH3 NOTCH4 | 2.31e-29 | 86 | 104 | 21 | PF07645 |
| Domain | EGF_Ca-bd_CS | COMP FAT3 EFEMP2 VWCE LRP1B SVEP1 NELL2 THBS4 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LTBP2 LTBP3 ADGRE1 FBN3 NOTCH2 NOTCH3 NOTCH4 | 3.83e-28 | 97 | 104 | 21 | IPR018097 |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | FAT3 EFEMP2 DLK1 VWCE LRP1B SVEP1 NELL2 FBLN2 FBN2 JAG1 SLIT3 LRP1 LRP2 LTBP2 LTBP3 ADGRE1 FBN3 NOTCH2 NOTCH3 NOTCH4 | 1.58e-25 | 106 | 104 | 20 | IPR000152 |
| Domain | ASX_HYDROXYL | FAT3 EFEMP2 DLK1 VWCE LRP1B SVEP1 NELL2 FBLN2 FBN2 JAG1 LRP1 LRP2 LTBP2 LTBP3 ADGRE1 FBN3 NOTCH2 NOTCH3 NOTCH4 | 2.40e-24 | 100 | 104 | 19 | PS00010 |
| Domain | EGF_Lam | LAMB4 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 STAB1 USH2A AGRN MEGF11 PEAR1 | 2.34e-23 | 35 | 104 | 14 | SM00180 |
| Domain | Laminin_EGF | LAMB4 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 STAB1 USH2A AGRN MEGF11 PEAR1 | 2.34e-23 | 35 | 104 | 14 | PF00053 |
| Domain | Laminin_EGF | LAMB4 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 STAB1 USH2A AGRN MEGF11 PEAR1 | 9.62e-23 | 38 | 104 | 14 | IPR002049 |
| Domain | EGF | HGFAC ZAN DLK1 LRP1B SVEP1 STAB1 THBS2 THBS4 JAG1 SLIT3 LRP1 LRP2 LRP5 LTBP2 AGRN FBN3 NOTCH2 NOTCH3 NOTCH4 | 2.58e-22 | 126 | 104 | 19 | PF00008 |
| Domain | EGF_LAM_2 | LAMB4 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 STAB1 USH2A AGRN | 3.67e-20 | 30 | 104 | 12 | PS50027 |
| Domain | EGF_LAM_1 | LAMB4 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 STAB1 USH2A AGRN | 3.67e-20 | 30 | 104 | 12 | PS01248 |
| Domain | Laminin_N | 4.00e-17 | 16 | 104 | 9 | IPR008211 | |
| Domain | LamNT | 4.00e-17 | 16 | 104 | 9 | SM00136 | |
| Domain | LAMININ_NTER | 4.00e-17 | 16 | 104 | 9 | PS51117 | |
| Domain | Laminin_N | 4.00e-17 | 16 | 104 | 9 | PF00055 | |
| Domain | EGF_extracell | ADAM19 ADAM15 DLK1 LRP1B SVEP1 STAB1 NELL2 JAG1 LRP2 LTBP2 MEGF11 NOTCH3 | 5.18e-16 | 60 | 104 | 12 | IPR013111 |
| Domain | EGF_2 | ADAM19 ADAM15 DLK1 LRP1B SVEP1 STAB1 NELL2 JAG1 LRP2 LTBP2 MEGF11 NOTCH3 | 5.18e-16 | 60 | 104 | 12 | PF07974 |
| Domain | - | COMP FAT3 LAMA1 LAMA2 LAMA5 LGALS12 SVEP1 NELL2 THBS2 THBS4 SLIT3 USH2A AGRN | 5.47e-15 | 95 | 104 | 13 | 2.60.120.200 |
| Domain | cEGF | 1.04e-14 | 26 | 104 | 9 | PF12662 | |
| Domain | cEGF | 1.04e-14 | 26 | 104 | 9 | IPR026823 | |
| Domain | hEGF | 2.29e-14 | 28 | 104 | 9 | PF12661 | |
| Domain | Laminin_G | 7.70e-13 | 58 | 104 | 10 | IPR001791 | |
| Domain | ConA-like_dom | ZAN COMP FAT3 LAMA1 LAMA2 LAMA5 LGALS12 SVEP1 NELL2 THBS2 THBS4 SLIT3 USH2A AGRN | 1.92e-11 | 219 | 104 | 14 | IPR013320 |
| Domain | VWF_dom | 7.10e-11 | 42 | 104 | 8 | IPR001007 | |
| Domain | LamG | 1.06e-10 | 44 | 104 | 8 | SM00282 | |
| Domain | - | 2.68e-10 | 8 | 104 | 5 | 3.90.290.10 | |
| Domain | LAMININ_IVA | 2.68e-10 | 8 | 104 | 5 | PS51115 | |
| Domain | Laminin_B | 2.68e-10 | 8 | 104 | 5 | PF00052 | |
| Domain | LamB | 2.68e-10 | 8 | 104 | 5 | SM00281 | |
| Domain | Laminin_IV | 2.68e-10 | 8 | 104 | 5 | IPR000034 | |
| Domain | TB_dom | 6.01e-10 | 9 | 104 | 5 | IPR017878 | |
| Domain | TB | 6.01e-10 | 9 | 104 | 5 | PS51364 | |
| Domain | VWC_out | 6.59e-10 | 19 | 104 | 6 | SM00215 | |
| Domain | VWC | 1.48e-09 | 38 | 104 | 7 | SM00214 | |
| Domain | LAM_G_DOMAIN | 1.48e-09 | 38 | 104 | 7 | PS50025 | |
| Domain | LDLR_class-A_CS | 2.17e-09 | 40 | 104 | 7 | IPR023415 | |
| Domain | Laminin_G_2 | 2.17e-09 | 40 | 104 | 7 | PF02210 | |
| Domain | Ldl_recept_a | 5.16e-09 | 45 | 104 | 7 | PF00057 | |
| Domain | LDLRA_1 | 8.26e-09 | 48 | 104 | 7 | PS01209 | |
| Domain | LDrepeatLR_classA_rpt | 9.59e-09 | 49 | 104 | 7 | IPR002172 | |
| Domain | LDLa | 9.59e-09 | 49 | 104 | 7 | SM00192 | |
| Domain | LDLRA_2 | 9.59e-09 | 49 | 104 | 7 | PS50068 | |
| Domain | TB | 3.13e-08 | 7 | 104 | 4 | PF00683 | |
| Domain | VWFC_1 | 4.38e-08 | 36 | 104 | 6 | PS01208 | |
| Domain | Galactose-bd-like | 5.27e-08 | 94 | 104 | 8 | IPR008979 | |
| Domain | VWFC_2 | 6.16e-08 | 38 | 104 | 6 | PS50184 | |
| Domain | Laminin_IV_B | 1.68e-07 | 3 | 104 | 3 | IPR013015 | |
| Domain | LAMININ_IVB | 1.68e-07 | 3 | 104 | 3 | PS51116 | |
| Domain | - | 2.01e-07 | 46 | 104 | 6 | 4.10.400.10 | |
| Domain | Notch | 6.68e-07 | 4 | 104 | 3 | IPR008297 | |
| Domain | NODP | 6.68e-07 | 4 | 104 | 3 | PF07684 | |
| Domain | Notch_NODP_dom | 6.68e-07 | 4 | 104 | 3 | IPR011656 | |
| Domain | Notch_NOD_dom | 6.68e-07 | 4 | 104 | 3 | IPR010660 | |
| Domain | NOD | 6.68e-07 | 4 | 104 | 3 | PF06816 | |
| Domain | NOD | 6.68e-07 | 4 | 104 | 3 | SM01338 | |
| Domain | NODP | 6.68e-07 | 4 | 104 | 3 | SM01339 | |
| Domain | TIL_dom | 8.70e-07 | 14 | 104 | 4 | IPR002919 | |
| Domain | Ldl_recept_b | 8.70e-07 | 14 | 104 | 4 | PF00058 | |
| Domain | LDLRB | 8.70e-07 | 14 | 104 | 4 | PS51120 | |
| Domain | LY | 1.18e-06 | 15 | 104 | 4 | SM00135 | |
| Domain | LDLR_classB_rpt | 1.18e-06 | 15 | 104 | 4 | IPR000033 | |
| Domain | VWF_type-D | 1.57e-06 | 16 | 104 | 4 | IPR001846 | |
| Domain | VWFD | 1.57e-06 | 16 | 104 | 4 | PS51233 | |
| Domain | VWD | 1.57e-06 | 16 | 104 | 4 | SM00216 | |
| Domain | VWD | 1.57e-06 | 16 | 104 | 4 | PF00094 | |
| Domain | TSP_3 | 1.66e-06 | 5 | 104 | 3 | PF02412 | |
| Domain | Laminin_domII | 1.66e-06 | 5 | 104 | 3 | IPR010307 | |
| Domain | TSP3 | 1.66e-06 | 5 | 104 | 3 | PS51234 | |
| Domain | TSP_CTER | 1.66e-06 | 5 | 104 | 3 | PS51236 | |
| Domain | Thrombospondin_3_rpt | 1.66e-06 | 5 | 104 | 3 | IPR017897 | |
| Domain | TSP_type-3_rpt | 1.66e-06 | 5 | 104 | 3 | IPR028974 | |
| Domain | Laminin_aI | 1.66e-06 | 5 | 104 | 3 | IPR009254 | |
| Domain | Laminin_I | 1.66e-06 | 5 | 104 | 3 | PF06008 | |
| Domain | Laminin_II | 1.66e-06 | 5 | 104 | 3 | PF06009 | |
| Domain | LNR | 1.66e-06 | 5 | 104 | 3 | PS50258 | |
| Domain | - | 1.66e-06 | 5 | 104 | 3 | 4.10.1080.10 | |
| Domain | Thrombospondin_C | 1.66e-06 | 5 | 104 | 3 | IPR008859 | |
| Domain | TSP_C | 1.66e-06 | 5 | 104 | 3 | PF05735 | |
| Domain | Thrombospondin_3-like_rpt | 1.66e-06 | 5 | 104 | 3 | IPR003367 | |
| Domain | Notch_dom | 5.78e-06 | 7 | 104 | 3 | IPR000800 | |
| Domain | Notch | 5.78e-06 | 7 | 104 | 3 | PF00066 | |
| Domain | NL | 5.78e-06 | 7 | 104 | 3 | SM00004 | |
| Domain | VWC | 1.68e-05 | 28 | 104 | 4 | PF00093 | |
| Domain | TSP_1 | 2.64e-05 | 63 | 104 | 5 | PF00090 | |
| Domain | Laminin_G_1 | 2.68e-05 | 11 | 104 | 3 | PF00054 | |
| Domain | DUF5050 | 3.07e-05 | 2 | 104 | 2 | IPR032485 | |
| Domain | DUF5050 | 3.07e-05 | 2 | 104 | 2 | PF16472 | |
| Domain | TSP1 | 3.08e-05 | 65 | 104 | 5 | SM00209 | |
| Domain | TSP1_rpt | 3.08e-05 | 65 | 104 | 5 | IPR000884 | |
| Domain | TSP1 | 3.08e-05 | 65 | 104 | 5 | PS50092 | |
| Domain | Unchr_dom_Cys-rich | 4.61e-05 | 13 | 104 | 3 | IPR014853 | |
| Pathway | PID_INTEGRIN4_PATHWAY | 1.10e-16 | 11 | 79 | 8 | M158 | |
| Pathway | KEGG_ECM_RECEPTOR_INTERACTION | LAMB4 COMP LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 THBS2 THBS4 AGRN | 8.74e-16 | 84 | 79 | 13 | M7098 |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAM19 COMP ADAM15 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 FBLN2 FBN2 LTBP2 LTBP3 AGRN FBN3 CAPN15 | 2.70e-15 | 300 | 79 | 19 | M610 |
| Pathway | PID_A6B1_A6B4_INTEGRIN_PATHWAY | 3.18e-12 | 46 | 79 | 9 | M239 | |
| Pathway | REACTOME_MET_ACTIVATES_PTK2_SIGNALING | 3.58e-12 | 30 | 79 | 8 | M27772 | |
| Pathway | REACTOME_LAMININ_INTERACTIONS | 3.58e-12 | 30 | 79 | 8 | M27216 | |
| Pathway | WP_ALPHA_6_BETA_4_SIGNALING | 8.39e-12 | 33 | 79 | 8 | M39503 | |
| Pathway | REACTOME_NON_INTEGRIN_MEMBRANE_ECM_INTERACTIONS | 3.42e-11 | 59 | 79 | 9 | M27218 | |
| Pathway | REACTOME_MET_PROMOTES_CELL_MOTILITY | 5.57e-11 | 41 | 79 | 8 | M27778 | |
| Pathway | PID_INTEGRIN1_PATHWAY | 9.76e-11 | 66 | 79 | 9 | M18 | |
| Pathway | REACTOME_SIGNALING_BY_MET | 5.12e-10 | 79 | 79 | 9 | M27643 | |
| Pathway | KEGG_SMALL_CELL_LUNG_CANCER | 8.96e-10 | 84 | 79 | 9 | M3228 | |
| Pathway | KEGG_FOCAL_ADHESION | LAMB4 COMP LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 THBS2 THBS4 | 1.01e-09 | 199 | 79 | 12 | M7253 |
| Pathway | WP_SMALL_CELL_LUNG_CANCER | 2.99e-09 | 96 | 79 | 9 | M39834 | |
| Pathway | WP_ALPHA_6_BETA_4_INTEGRIN_SIGNALING_PATHWAY | 2.99e-09 | 66 | 79 | 8 | MM15925 | |
| Pathway | REACTOME_ECM_PROTEOGLYCANS | 9.39e-09 | 76 | 79 | 8 | M27219 | |
| Pathway | WP_FOCAL_ADHESION | COMP LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 THBS2 THBS4 | 1.32e-08 | 199 | 79 | 11 | M39402 |
| Pathway | WP_CANCER_PATHWAYS | LAMB4 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 KEAP1 STAT6 JAG1 LRP5 NOTCH2 NOTCH3 NOTCH4 | 1.65e-08 | 507 | 79 | 16 | M48302 |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 5.17e-08 | 37 | 79 | 6 | M27134 | |
| Pathway | REACTOME_DEGRADATION_OF_THE_EXTRACELLULAR_MATRIX | 8.29e-08 | 140 | 79 | 9 | M587 | |
| Pathway | WP_FOCAL_ADHESION | 8.65e-08 | 187 | 79 | 10 | MM15913 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 1.52e-07 | 44 | 79 | 6 | M26969 | |
| Pathway | WP_CANONICAL_AND_NONCANONICAL_NOTCH_SIGNALING | 3.56e-07 | 27 | 79 | 5 | M39545 | |
| Pathway | WP_PI3KAKT_SIGNALING | LAMB4 COMP LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 THBS2 THBS4 | 3.71e-07 | 339 | 79 | 12 | M39736 |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00380 | 4.37e-07 | 12 | 79 | 4 | M47532 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 6.21e-07 | 30 | 79 | 5 | M39641 | |
| Pathway | WP_INFLAMMATORY_RESPONSE_PATHWAY | 6.21e-07 | 30 | 79 | 5 | MM15812 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_SIGNALING_PATHWAY | 6.29e-07 | 13 | 79 | 4 | M47423 | |
| Pathway | REACTOME_MOLECULES_ASSOCIATED_WITH_ELASTIC_FIBRES | 8.70e-07 | 32 | 79 | 5 | MM14854 | |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTORSIGNALING | COMP LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 THBS2 THBS4 | 9.00e-07 | 302 | 79 | 11 | M39719 |
| Pathway | REACTOME_SIGNALING_BY_RECEPTOR_TYROSINE_KINASES | PCSK5 HGFAC ERBB3 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 STAT6 THBS2 THBS4 | 1.30e-06 | 532 | 79 | 14 | M27870 |
| Pathway | REACTOME_DEFECTIVE_LFNG_CAUSES_SCDO3 | 1.68e-06 | 5 | 79 | 3 | M27411 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | ADAM19 COMP ADAM15 EFEMP2 FBLN2 FBN2 LTBP2 LTBP3 AGRN CAPN15 | 1.68e-06 | 258 | 79 | 10 | MM14572 |
| Pathway | WP_FOCAL_ADHESION_PI3KAKTMTOR_SIGNALING_PATHWAY | COMP LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 THBS2 THBS4 | 1.90e-06 | 326 | 79 | 11 | MM15917 |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | 2.12e-06 | 68 | 79 | 6 | M27303 | |
| Pathway | REACTOME_ELASTIC_FIBRE_FORMATION | 2.41e-06 | 39 | 79 | 5 | MM14601 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_THE_ENDOPLASMIC_RETICULUM | 3.35e-06 | 6 | 79 | 3 | M27068 | |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | 1.50e-05 | 143 | 79 | 7 | M27275 | |
| Pathway | WP_COMPLEMENT_SYSTEM | 1.59e-05 | 96 | 79 | 6 | M39581 | |
| Pathway | PID_NOTCH_PATHWAY | 1.92e-05 | 59 | 79 | 5 | M17 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_PROTEOLYTIC_ACTIVATION | 2.71e-05 | 11 | 79 | 3 | M47865 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 3.59e-05 | 12 | 79 | 3 | M22020 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00381 | 3.59e-05 | 12 | 79 | 3 | M47533 | |
| Pathway | KEGG_MEDICUS_PATHOGEN_HPV_E6_TO_NOTCH_SIGNALING_PATHWAY_N00382 | 4.65e-05 | 13 | 79 | 3 | M47534 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.07e-05 | 72 | 79 | 5 | M39403 | |
| Pathway | WP_PRIMARY_FOCAL_SEGMENTAL_GLOMERULOSCLEROSIS_FSGS | 5.42e-05 | 73 | 79 | 5 | MM15906 | |
| Pathway | KEGG_PATHWAYS_IN_CANCER | 8.21e-05 | 325 | 79 | 9 | M12868 | |
| Pathway | WP_NOTCH_SIGNALING_WP268 | 1.14e-04 | 45 | 79 | 4 | M39571 | |
| Pathway | WP_NOTCH_SIGNALING_PATHWAY | 1.25e-04 | 46 | 79 | 4 | MM15971 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 1.30e-04 | 18 | 79 | 3 | M614 | |
| Pathway | KEGG_NOTCH_SIGNALING_PATHWAY | 1.36e-04 | 47 | 79 | 4 | M7946 | |
| Pathway | REACTOME_NOTCH2_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 2.42e-04 | 22 | 79 | 3 | M27210 | |
| Pathway | WP_EPITHELIAL_TO_MESENCHYMAL_TRANSITION_IN_COLORECTAL_CANCER | 2.82e-04 | 161 | 79 | 6 | M39770 | |
| Pathway | REACTOME_PRE_NOTCH_PROCESSING_IN_GOLGI | 3.07e-04 | 5 | 79 | 2 | MM14733 | |
| Pathway | KEGG_DORSO_VENTRAL_AXIS_FORMATION | 3.15e-04 | 24 | 79 | 3 | M11190 | |
| Pathway | WP_HYPOTHESIZED_PATHWAYS_IN_PATHOGENESIS_OF_CARDIOVASCULAR_DISEASE | 3.56e-04 | 25 | 79 | 3 | M39713 | |
| Pathway | REACTOME_NOTCH3_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 3.56e-04 | 25 | 79 | 3 | M27879 | |
| Pathway | WP_NOTCH_SIGNALING_WP61 | 3.74e-04 | 61 | 79 | 4 | M39540 | |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | 4.96e-04 | 250 | 79 | 7 | M27554 | |
| Pathway | REACTOME_NOTCH_HLH_TRANSCRIPTION_PATHWAY | 5.02e-04 | 28 | 79 | 3 | M6177 | |
| Pathway | WP_OSTEOBLAST_DIFFERENTIATION_AND_RELATED_DISEASES | 5.19e-04 | 118 | 79 | 5 | M39852 | |
| Pathway | REACTOME_EGR2_AND_SOX10_MEDIATED_INITIATION_OF_SCHWANN_CELL_MYELINATION | 5.57e-04 | 29 | 79 | 3 | M29808 | |
| Pathway | KEGG_MEDICUS_REFERENCE_COMMON_PATHWAY_OF_COMPLEMENT_CASCADE_MAC_FORMATION | 6.39e-04 | 7 | 79 | 2 | M47873 | |
| Pathway | REACTOME_PRE_NOTCH_EXPRESSION_AND_PROCESSING | 6.39e-04 | 7 | 79 | 2 | MM14734 | |
| Pathway | BIOCARTA_AGR_PATHWAY | 6.80e-04 | 31 | 79 | 3 | MM1343 | |
| Pathway | REACTOME_ACTIVATED_NOTCH1_TRANSMITS_SIGNAL_TO_THE_NUCLEUS | 6.80e-04 | 31 | 79 | 3 | M592 | |
| Pathway | WP_PLEURAL_MESOTHELIOMA | 7.58e-04 | 439 | 79 | 9 | M42563 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH2 | 8.19e-04 | 33 | 79 | 3 | M604 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 8.49e-04 | 8 | 79 | 2 | MM14656 | |
| Pathway | REACTOME_TERMINAL_PATHWAY_OF_COMPLEMENT | 8.49e-04 | 8 | 79 | 2 | M27006 | |
| Pathway | WP_OSX_AND_MIRNAS_IN_TOOTH_DEVELOPMENT | 8.94e-04 | 34 | 79 | 3 | M39390 | |
| Pathway | KEGG_PRION_DISEASES | 9.74e-04 | 35 | 79 | 3 | M13036 | |
| Pathway | BIOCARTA_ALTERNATIVE_PATHWAY | 1.09e-03 | 9 | 79 | 2 | M22072 | |
| Pathway | KEGG_MEDICUS_REFERENCE_REGULATION_OF_COMPLEMENT_CASCADE_MAC_INHIBITION | 1.09e-03 | 9 | 79 | 2 | M47881 | |
| Pathway | KEGG_MEDICUS_REFERENCE_NOTCH_LIGAND_UBIQUITYLATION | 1.09e-03 | 9 | 79 | 2 | M47866 | |
| Pathway | WP_DELTANOTCH_SIGNALING_PATHWAY | 1.15e-03 | 82 | 79 | 4 | MM15922 | |
| Pathway | WP_NEOVASCULARIZATION_PROCESSES | 1.15e-03 | 37 | 79 | 3 | M39506 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 1.34e-03 | 39 | 79 | 3 | MM14604 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.34e-03 | 39 | 79 | 3 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.34e-03 | 39 | 79 | 3 | MM15165 | |
| Pathway | BIOCARTA_PRION_PATHWAY | 1.36e-03 | 10 | 79 | 2 | MM1545 | |
| Pathway | REACTOME_REGULATION_OF_COMMISSURAL_AXON_PATHFINDING_BY_SLIT_AND_ROBO | 1.36e-03 | 10 | 79 | 2 | M27348 | |
| Pathway | REACTOME_TYPE_I_HEMIDESMOSOME_ASSEMBLY | 1.65e-03 | 11 | 79 | 2 | M27372 | |
| Pathway | REACTOME_NOTCH4_ACTIVATION_AND_TRANSMISSION_OF_SIGNAL_TO_THE_NUCLEUS | 1.65e-03 | 11 | 79 | 2 | M27882 | |
| Pathway | WP_MIRNA_TARGETS_IN_ECM_AND_MEMBRANE_RECEPTORS | 1.78e-03 | 43 | 79 | 3 | M39565 | |
| Pathway | WP_COMPLEMENTMEDIATED_INFLAMMATION_OF_PULMONARY_ALVEOLUS_IN_COVID19_HYPOTHETICAL_PATHWAY | 1.97e-03 | 12 | 79 | 2 | M48316 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.03e-03 | 45 | 79 | 3 | MM15344 | |
| Pathway | BIOCARTA_LECTIN_PATHWAY | 2.32e-03 | 13 | 79 | 2 | M4732 | |
| Pathway | REACTOME_METABOLISM_OF_FAT_SOLUBLE_VITAMINS | 2.44e-03 | 48 | 79 | 3 | M27642 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH | 2.55e-03 | 246 | 79 | 6 | M10189 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH3 | 2.59e-03 | 49 | 79 | 3 | M618 | |
| Pathway | REACTOME_INTERLEUKIN_4_AND_INTERLEUKIN_13_SIGNALING | 2.70e-03 | 14 | 79 | 2 | MM15321 | |
| Pathway | REACTOME_ANCHORING_FIBRIL_FORMATION | 3.11e-03 | 15 | 79 | 2 | M27161 | |
| Pathway | REACTOME_SIGNALING_BY_NOTCH1_HD_DOMAIN_MUTANTS_IN_CANCER | 3.11e-03 | 15 | 79 | 2 | M27202 | |
| Pathway | BIOCARTA_CLASSIC_PATHWAY | 3.11e-03 | 15 | 79 | 2 | M7146 | |
| Pathway | KEGG_MEDICUS_VARIANT_NOTCH_OVEREXPRESSION_TO_NOTCH_SIGNALING_PATHWAY | 3.54e-03 | 16 | 79 | 2 | M47424 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 3.99e-03 | 57 | 79 | 3 | MM14713 | |
| Pathway | WP_REGULATION_OF_WNT_BCATENIN_SIGNALING_BY_SMALL_MOLECULE_COMPOUNDS | 3.99e-03 | 17 | 79 | 2 | M39525 | |
| Pathway | WP_COMPLEMENT_ACTIVATION_CLASSICAL_PATHWAY | 3.99e-03 | 17 | 79 | 2 | MM15944 | |
| Pathway | REACTOME_SIGNALING_BY_PDGF | 4.19e-03 | 58 | 79 | 3 | M2049 | |
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | PCSK5 COMP FSTL3 ADAM15 EFEMP2 LAMA1 LAMA2 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLA1A ADAMTS7 SLIT3 LTBP2 AGRN DKK3 | 4.90e-23 | 248 | 105 | 20 | 24006456 |
| Pubmed | ADAMTSL1 ADAM19 EFEMP2 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 ECM1 THBS4 FBLN2 PLXDC2 LTBP2 AGRN | 1.90e-21 | 167 | 105 | 17 | 22159717 | |
| Pubmed | 2.35e-19 | 10 | 105 | 8 | 9034910 | ||
| Pubmed | 6.97e-19 | 18 | 105 | 9 | 11311202 | ||
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 8.61e-19 | 11 | 105 | 8 | 23472759 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 8.61e-19 | 11 | 105 | 8 | 21524702 | |
| Pubmed | 2.58e-18 | 12 | 105 | 8 | 9396756 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 3.32e-17 | 15 | 105 | 8 | 15895400 | |
| Pubmed | 4.39e-17 | 26 | 105 | 9 | 24742657 | ||
| Pubmed | 6.63e-17 | 16 | 105 | 8 | 17601529 | ||
| Pubmed | 1.40e-16 | 29 | 105 | 9 | 22613833 | ||
| Pubmed | 6.43e-16 | 20 | 105 | 8 | 22911573 | ||
| Pubmed | 3.15e-15 | 13 | 105 | 7 | 12682087 | ||
| Pubmed | 4.57e-15 | 7 | 105 | 6 | 14557481 | ||
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 1.18e-14 | 15 | 105 | 7 | 12921739 | |
| Pubmed | 1.18e-14 | 15 | 105 | 7 | 9264260 | ||
| Pubmed | Expression and localization of laminin-5 subunits during mouse tooth development. | 1.83e-14 | 8 | 105 | 6 | 9489770 | |
| Pubmed | 1.83e-14 | 8 | 105 | 6 | 8872465 | ||
| Pubmed | COMP LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 ECM1 THBS2 FBLN2 LTBP2 LTBP3 AGRN | 2.64e-14 | 146 | 105 | 12 | 27068509 | |
| Pubmed | Transcriptome-based systematic identification of extracellular matrix proteins. | 4.91e-14 | 79 | 105 | 10 | 18757743 | |
| Pubmed | 1.36e-13 | 10 | 105 | 6 | 11784026 | ||
| Pubmed | 2.28e-13 | 5 | 105 | 5 | 10964500 | ||
| Pubmed | 2.28e-13 | 5 | 105 | 5 | 9719032 | ||
| Pubmed | 2.28e-13 | 5 | 105 | 5 | 12743034 | ||
| Pubmed | ADAMTSL1 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 ECM1 FBLN2 FBN2 LTBP2 AGRN | 2.34e-13 | 175 | 105 | 12 | 28071719 | |
| Pubmed | 3.73e-13 | 40 | 105 | 8 | 27068110 | ||
| Pubmed | 1.10e-12 | 13 | 105 | 6 | 36350252 | ||
| Pubmed | Protein interactome reveals converging molecular pathways among autism disorders. | EFEMP2 LAMA5 LAMB2 LAMC1 VWCE ECM1 STAB1 NELL2 FBLN2 LINGO1 LTBP3 AGRN MEGF11 DKK3 NOTCH2 NOTCH3 AGAP3 | 1.15e-12 | 560 | 105 | 17 | 21653829 |
| Pubmed | Adamts18 modulates the development of the aortic arch and common carotid artery. | 1.17e-12 | 26 | 105 | 7 | 34189436 | |
| Pubmed | 1.36e-12 | 6 | 105 | 5 | 1678389 | ||
| Pubmed | 1.36e-12 | 6 | 105 | 5 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 1.36e-12 | 6 | 105 | 5 | 3794389 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 1.36e-12 | 6 | 105 | 5 | 3109910 | |
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 1.36e-12 | 6 | 105 | 5 | 23948589 | |
| Pubmed | 1.36e-12 | 6 | 105 | 5 | 2119632 | ||
| Pubmed | Expression and localization of laminin-5 subunits in the mouse incisor. | 1.36e-12 | 6 | 105 | 5 | 9506922 | |
| Pubmed | Abscence of laminin alpha1 chain in the skeletal muscle of dystrophic dy/dy mice. | 4.76e-12 | 7 | 105 | 5 | 9390664 | |
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 1.18e-11 | 18 | 105 | 6 | 23041440 | |
| Pubmed | 1.18e-11 | 18 | 105 | 6 | 14730302 | ||
| Pubmed | ADAMTS18-fibronectin interaction regulates the morphology of liver sinusoidal endothelial cells. | 1.18e-11 | 18 | 105 | 6 | 39040056 | |
| Pubmed | Spatial and temporal control of laminin-332 and -511 expressions during hair morphogenesis. | 1.27e-11 | 8 | 105 | 5 | 23529140 | |
| Pubmed | Integrin-laminin interactions controlling neurite outgrowth from adult DRG neurons in vitro. | 5.67e-11 | 10 | 105 | 5 | 18590826 | |
| Pubmed | Expression of laminin chains by central neurons: analysis with gene and protein trapping techniques. | 7.84e-11 | 4 | 105 | 4 | 12820173 | |
| Pubmed | 7.84e-11 | 4 | 105 | 4 | 2099832 | ||
| Pubmed | 7.84e-11 | 4 | 105 | 4 | 9299121 | ||
| Pubmed | Regulation and Function of Laminin A5 during Mouse and Human Decidualization. | 7.84e-11 | 4 | 105 | 4 | 35008625 | |
| Pubmed | 7.84e-11 | 4 | 105 | 4 | 8034675 | ||
| Pubmed | 1.00e-10 | 118 | 105 | 9 | 21078624 | ||
| Pubmed | 1.68e-10 | 50 | 105 | 7 | 23658023 | ||
| Pubmed | 1.77e-10 | 12 | 105 | 5 | 16750824 | ||
| Pubmed | Characterization of the Extracellular Matrix of Normal and Diseased Tissues Using Proteomics. | 3.35e-10 | 135 | 105 | 9 | 28675934 | |
| Pubmed | 3.91e-10 | 257 | 105 | 11 | 16335952 | ||
| Pubmed | 3.91e-10 | 5 | 105 | 4 | 11969289 | ||
| Pubmed | Expression of laminin isoforms in mouse myogenic cells in vitro and in vivo. | 3.91e-10 | 5 | 105 | 4 | 8719886 | |
| Pubmed | 3.91e-10 | 5 | 105 | 4 | 15882997 | ||
| Pubmed | Laminin alpha 2 chain (M chain) is found within the pathway of avian and murine retinal projections. | 3.91e-10 | 5 | 105 | 4 | 8613743 | |
| Pubmed | 3.91e-10 | 5 | 105 | 4 | 7851641 | ||
| Pubmed | ESCPE-1 mediates retrograde endosomal sorting of the SARS-CoV-2 host factor Neuropilin-1. | FSTL3 ENPP1 ADAM15 LAMA1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ECM1 LRP1B NELL2 FBN2 LRP1 LRP5 LTBP2 LTBP3 AGRN NOTCH2 NOTCH3 | 4.84e-10 | 1201 | 105 | 20 | 35696571 |
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 6.09e-10 | 97 | 105 | 8 | 27559042 | |
| Pubmed | 6.68e-10 | 15 | 105 | 5 | 10625553 | ||
| Pubmed | 1.01e-09 | 64 | 105 | 7 | 22261194 | ||
| Pubmed | 1.02e-09 | 153 | 105 | 9 | 25037231 | ||
| Pubmed | Characterization of Notch receptor expression in the developing mammalian heart and liver. | 1.17e-09 | 6 | 105 | 4 | 12244553 | |
| Pubmed | Laminin-10 and Lutheran blood group glycoproteins in adhesion of human endothelial cells. | 1.17e-09 | 6 | 105 | 4 | 16236823 | |
| Pubmed | 1.17e-09 | 6 | 105 | 4 | 10671376 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 1.37e-09 | 17 | 105 | 5 | 15056720 | |
| Pubmed | Segmental expression of Notch and Hairy genes in nephrogenesis. | 1.37e-09 | 17 | 105 | 5 | 15821257 | |
| Pubmed | 2.73e-09 | 7 | 105 | 4 | 10079256 | ||
| Pubmed | The distribution of Notch receptors and their ligands during articular cartilage development. | 2.73e-09 | 7 | 105 | 4 | 12846471 | |
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 2.73e-09 | 7 | 105 | 4 | 9004048 | |
| Pubmed | 2.73e-09 | 7 | 105 | 4 | 7921537 | ||
| Pubmed | 2.73e-09 | 7 | 105 | 4 | 11891225 | ||
| Pubmed | 5.40e-09 | 81 | 105 | 7 | 39217171 | ||
| Pubmed | 5.44e-09 | 8 | 105 | 4 | 9858718 | ||
| Pubmed | 5.44e-09 | 8 | 105 | 4 | 32439764 | ||
| Pubmed | 5.44e-09 | 8 | 105 | 4 | 22156581 | ||
| Pubmed | 5.44e-09 | 8 | 105 | 4 | 9852162 | ||
| Pubmed | Notch1 and Jagged1 expression by the developing pulmonary vasculature. | 5.44e-09 | 8 | 105 | 4 | 12242716 | |
| Pubmed | 9.77e-09 | 9 | 105 | 4 | 11118901 | ||
| Pubmed | 9.77e-09 | 9 | 105 | 4 | 16245338 | ||
| Pubmed | 9.77e-09 | 9 | 105 | 4 | 15102706 | ||
| Pubmed | ERp57 is essential for efficient folding of glycoproteins sharing common structural domains. | 1.15e-08 | 25 | 105 | 5 | 17170699 | |
| Pubmed | 1.42e-08 | 26 | 105 | 5 | 25446530 | ||
| Pubmed | 1.62e-08 | 10 | 105 | 4 | 22911783 | ||
| Pubmed | Spatiotemporal expression of Notch receptors and ligands in developing mouse placenta. | 1.62e-08 | 10 | 105 | 4 | 23665443 | |
| Pubmed | 1.62e-08 | 10 | 105 | 4 | 15623520 | ||
| Pubmed | Generation of a conditionally null allele of the laminin alpha1 gene. | 1.62e-08 | 10 | 105 | 4 | 16100707 | |
| Pubmed | Integrin alpha6beta1-laminin interactions regulate early myotome formation in the mouse embryo. | 1.62e-08 | 10 | 105 | 4 | 16554364 | |
| Pubmed | 1.64e-08 | 210 | 105 | 9 | 16537572 | ||
| Pubmed | Structural basis for endosomal trafficking of diverse transmembrane cargos by PX-FERM proteins. | 2.54e-08 | 101 | 105 | 7 | 23382219 | |
| Pubmed | 2.55e-08 | 11 | 105 | 4 | 24639464 | ||
| Pubmed | A family of mammalian Fringe genes implicated in boundary determination and the Notch pathway. | 2.55e-08 | 11 | 105 | 4 | 9187150 | |
| Pubmed | Coexpression of Cux-1 and Notch signaling pathway components during kidney development. | 2.55e-08 | 11 | 105 | 4 | 15499562 | |
| Pubmed | 2.55e-08 | 11 | 105 | 4 | 12051813 | ||
| Pubmed | 2.55e-08 | 11 | 105 | 4 | 10878608 | ||
| Pubmed | 2.55e-08 | 11 | 105 | 4 | 12866128 | ||
| Pubmed | Notch signaling in stomach epithelial stem cell homeostasis. | 2.55e-08 | 29 | 105 | 5 | 21402740 | |
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 2100263 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 30502484 | ||
| Pubmed | 2.67e-08 | 3 | 105 | 3 | 7669546 | ||
| Interaction | IGFL3 interactions | PCSK5 LAMA1 LAMA5 LAMB1 LAMB2 LRP1B VWDE FBN2 ADAMTS7 LRP2 LRP5 AGRN NOTCH2 NOTCH3 | 1.44e-18 | 75 | 103 | 14 | int:IGFL3 |
| Interaction | FBXO2 interactions | PCSK5 ENPP1 LAMA1 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 LRP1B ST14 NELL2 LRFN4 FBN2 LINGO1 ADAMTS7 JAG1 LRP2 C8A AGRN NOTCH2 NOTCH3 | 1.23e-16 | 411 | 103 | 22 | int:FBXO2 |
| Interaction | CFC1 interactions | PCSK5 ADAM19 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 VWDE ST14 ADAMTS7 LRP5 AGRN NOTCH2 | 7.89e-14 | 126 | 103 | 13 | int:CFC1 |
| Interaction | PRG2 interactions | PCSK5 ADAM15 LAMA5 LAMB2 LAMB3 LAMC1 LAMC2 VWDE ST14 FBN2 ADAMTS7 LRP5 LTBP3 NOTCH2 NOTCH3 | 1.68e-11 | 285 | 103 | 15 | int:PRG2 |
| Interaction | PI15 interactions | 4.01e-10 | 83 | 103 | 9 | int:PI15 | |
| Interaction | ZFP41 interactions | 4.75e-10 | 57 | 103 | 8 | int:ZFP41 | |
| Interaction | ZNF627 interactions | 5.63e-10 | 20 | 103 | 6 | int:ZNF627 | |
| Interaction | ELSPBP1 interactions | 1.02e-09 | 92 | 103 | 9 | int:ELSPBP1 | |
| Interaction | NTN5 interactions | 1.92e-09 | 24 | 103 | 6 | int:NTN5 | |
| Interaction | NUFIP2 interactions | PCSK5 COMP EFEMP2 VWCE STAB1 NELL2 FBLN2 LTBP2 LTBP3 AGRN MEGF11 DKK3 NOTCH3 PEAR1 AGAP3 | 3.30e-09 | 417 | 103 | 15 | int:NUFIP2 |
| Interaction | SLURP1 interactions | PCSK5 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 ST14 NELL2 ADAMTS7 NOTCH2 | 3.39e-09 | 144 | 103 | 10 | int:SLURP1 |
| Interaction | ZNF408 interactions | 3.63e-09 | 145 | 103 | 10 | int:ZNF408 | |
| Interaction | HOXA1 interactions | PCSK5 KRT83 EFEMP2 LAMA5 LAMB2 VWCE NELL2 FBLN2 VWC2L LTBP3 AGRN DKK3 NOTCH3 AGAP3 | 3.72e-09 | 356 | 103 | 14 | int:HOXA1 |
| Interaction | EDN3 interactions | 4.29e-09 | 108 | 103 | 9 | int:EDN3 | |
| Interaction | TIMP3 interactions | 1.94e-08 | 90 | 103 | 8 | int:TIMP3 | |
| Interaction | FBN2 interactions | 4.05e-08 | 65 | 103 | 7 | int:FBN2 | |
| Interaction | DNAJB9 interactions | 8.60e-08 | 202 | 103 | 10 | int:DNAJB9 | |
| Interaction | SDF2L1 interactions | PCSK5 ADAM19 ADAM15 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 VWDE ADAMTS7 LRP5 AGRN | 9.41e-08 | 322 | 103 | 12 | int:SDF2L1 |
| Interaction | EGFL7 interactions | 1.33e-07 | 77 | 103 | 7 | int:EGFL7 | |
| Interaction | NCR3 interactions | 1.85e-07 | 120 | 103 | 8 | int:NCR3 | |
| Interaction | LYPD4 interactions | 2.24e-07 | 123 | 103 | 8 | int:LYPD4 | |
| Interaction | CACNA1A interactions | 2.24e-07 | 123 | 103 | 8 | int:CACNA1A | |
| Interaction | NTF3 interactions | 2.33e-07 | 27 | 103 | 5 | int:NTF3 | |
| Interaction | NID2 interactions | 2.86e-07 | 86 | 103 | 7 | int:NID2 | |
| Interaction | FBLN1 interactions | 3.24e-07 | 129 | 103 | 8 | int:FBLN1 | |
| Interaction | GPIHBP1 interactions | 4.09e-07 | 133 | 103 | 8 | int:GPIHBP1 | |
| Interaction | LTBP1 interactions | 4.55e-07 | 92 | 103 | 7 | int:LTBP1 | |
| Interaction | ZNF664 interactions | 4.83e-07 | 31 | 103 | 5 | int:ZNF664 | |
| Interaction | LYPD1 interactions | 5.02e-07 | 58 | 103 | 6 | int:LYPD1 | |
| Interaction | MANEA interactions | 6.16e-07 | 60 | 103 | 6 | int:MANEA | |
| Interaction | RNASE4 interactions | 6.19e-07 | 14 | 103 | 4 | int:RNASE4 | |
| Interaction | MSTN interactions | 6.70e-07 | 33 | 103 | 5 | int:MSTN | |
| Interaction | FBLN2 interactions | 1.09e-06 | 66 | 103 | 6 | int:FBLN2 | |
| Interaction | LAMA1 interactions | 1.09e-06 | 66 | 103 | 6 | int:LAMA1 | |
| Interaction | ZNF696 interactions | 1.30e-06 | 68 | 103 | 6 | int:ZNF696 | |
| Interaction | LYPD6B interactions | 1.59e-06 | 39 | 103 | 5 | int:LYPD6B | |
| Interaction | LY86 interactions | 1.72e-06 | 217 | 103 | 9 | int:LY86 | |
| Interaction | ZNF358 interactions | 2.35e-06 | 19 | 103 | 4 | int:ZNF358 | |
| Interaction | CRP interactions | 2.72e-06 | 77 | 103 | 6 | int:CRP | |
| Interaction | ZNF224 interactions | 2.93e-06 | 20 | 103 | 4 | int:ZNF224 | |
| Interaction | MAML3 interactions | 2.93e-06 | 20 | 103 | 4 | int:MAML3 | |
| Interaction | INHBE interactions | 3.28e-06 | 45 | 103 | 5 | int:INHBE | |
| Interaction | IL5RA interactions | 3.42e-06 | 124 | 103 | 7 | int:IL5RA | |
| Interaction | FBXO6 interactions | ENPP1 ADAM15 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 VWDE LRFN4 FBN2 ADAMTS7 LRP1 LTBP3 AGRN VARS1 | 3.57e-06 | 717 | 103 | 15 | int:FBXO6 |
| Interaction | CCL3 interactions | 3.68e-06 | 178 | 103 | 8 | int:CCL3 | |
| Interaction | THBS1 interactions | 4.01e-06 | 127 | 103 | 7 | int:THBS1 | |
| Interaction | ZNF594 interactions | 4.47e-06 | 7 | 103 | 3 | int:ZNF594 | |
| Interaction | PRG3 interactions | 5.04e-06 | 49 | 103 | 5 | int:PRG3 | |
| Interaction | ATN1 interactions | 5.30e-06 | 187 | 103 | 8 | int:ATN1 | |
| Interaction | FBN1 interactions | 6.16e-06 | 51 | 103 | 5 | int:FBN1 | |
| Interaction | MFAP5 interactions | 6.79e-06 | 52 | 103 | 5 | int:MFAP5 | |
| Interaction | COL7A1 interactions | 7.49e-06 | 25 | 103 | 4 | int:COL7A1 | |
| Interaction | LINGO1 interactions | 8.20e-06 | 54 | 103 | 5 | int:LINGO1 | |
| Interaction | CLEC11A interactions | 9.83e-06 | 96 | 103 | 6 | int:CLEC11A | |
| Interaction | CXCL5 interactions | 1.03e-05 | 27 | 103 | 4 | int:CXCL5 | |
| Interaction | ST14 interactions | 1.12e-05 | 207 | 103 | 8 | int:ST14 | |
| Interaction | TRIM68 interactions | 1.32e-05 | 101 | 103 | 6 | int:TRIM68 | |
| Interaction | PLAT interactions | 1.76e-05 | 63 | 103 | 5 | int:PLAT | |
| Interaction | JAG2 interactions | 2.14e-05 | 110 | 103 | 6 | int:JAG2 | |
| Interaction | C1orf54 interactions | 2.40e-05 | 167 | 103 | 7 | int:C1orf54 | |
| Interaction | DYRK1A interactions | ERBB3 ADAM19 EFEMP2 LAMB1 KEAP1 LRP1B STAB1 NELL2 LRP2 LTBP3 DKK3 NOTCH2 | 2.51e-05 | 552 | 103 | 12 | int:DYRK1A |
| Interaction | VEGFB interactions | 2.65e-05 | 34 | 103 | 4 | int:VEGFB | |
| Interaction | C1QTNF7 interactions | 2.74e-05 | 69 | 103 | 5 | int:C1QTNF7 | |
| Interaction | NDP interactions | 2.98e-05 | 35 | 103 | 4 | int:NDP | |
| Interaction | LAMA5 interactions | 3.04e-05 | 117 | 103 | 6 | int:LAMA5 | |
| Interaction | LYZL1 interactions | 3.19e-05 | 118 | 103 | 6 | int:LYZL1 | |
| Interaction | BCAN interactions | 3.34e-05 | 36 | 103 | 4 | int:BCAN | |
| Interaction | B3GLCT interactions | 3.34e-05 | 36 | 103 | 4 | int:B3GLCT | |
| Interaction | ZNF709 interactions | 3.57e-05 | 13 | 103 | 3 | int:ZNF709 | |
| Interaction | GREM2 interactions | 3.73e-05 | 37 | 103 | 4 | int:GREM2 | |
| Interaction | ZDHHC15 interactions | 4.42e-05 | 125 | 103 | 6 | int:ZDHHC15 | |
| Interaction | CRISP2 interactions | 5.10e-05 | 40 | 103 | 4 | int:CRISP2 | |
| Interaction | LGALS1 interactions | 5.17e-05 | 332 | 103 | 9 | int:LGALS1 | |
| Interaction | NOTCH2 interactions | 6.19e-05 | 423 | 103 | 10 | int:NOTCH2 | |
| Interaction | PLAUR interactions | 6.79e-05 | 135 | 103 | 6 | int:PLAUR | |
| Interaction | ZNF628 interactions | 6.92e-05 | 16 | 103 | 3 | int:ZNF628 | |
| Interaction | DEFB136 interactions | 7.46e-05 | 44 | 103 | 4 | int:DEFB136 | |
| Interaction | SIRPD interactions | 7.93e-05 | 86 | 103 | 5 | int:SIRPD | |
| Interaction | MAML2 interactions | 8.37e-05 | 17 | 103 | 3 | int:MAML2 | |
| Interaction | KLKB1 interactions | 8.37e-05 | 17 | 103 | 3 | int:KLKB1 | |
| Interaction | ZNF316 interactions | 8.90e-05 | 46 | 103 | 4 | int:ZNF316 | |
| Interaction | ZNF324 interactions | 8.90e-05 | 46 | 103 | 4 | int:ZNF324 | |
| Interaction | ZNF865 interactions | 9.69e-05 | 47 | 103 | 4 | int:ZNF865 | |
| Interaction | NID1 interactions | 1.05e-04 | 48 | 103 | 4 | int:NID1 | |
| Interaction | WNT3A interactions | 1.14e-04 | 49 | 103 | 4 | int:WNT3A | |
| Interaction | DEFB125 interactions | 1.39e-04 | 20 | 103 | 3 | int:DEFB125 | |
| Interaction | WDR76 interactions | 1.53e-04 | 383 | 103 | 9 | int:WDR76 | |
| Interaction | ZNF142 interactions | 1.61e-04 | 21 | 103 | 3 | int:ZNF142 | |
| Interaction | NOTCH4 interactions | 1.61e-04 | 21 | 103 | 3 | int:NOTCH4 | |
| Interaction | DEFA1 interactions | 1.62e-04 | 100 | 103 | 5 | int:DEFA1 | |
| Interaction | SMOC1 interactions | 1.67e-04 | 54 | 103 | 4 | int:SMOC1 | |
| Interaction | ZNF77 interactions | 1.86e-04 | 22 | 103 | 3 | int:ZNF77 | |
| Interaction | INSL5 interactions | 2.21e-04 | 58 | 103 | 4 | int:INSL5 | |
| Interaction | ATXN7 interactions | 2.43e-04 | 109 | 103 | 5 | int:ATXN7 | |
| Interaction | NOTCH3 interactions | 2.87e-04 | 113 | 103 | 5 | int:NOTCH3 | |
| Interaction | PTPRK interactions | 2.98e-04 | 177 | 103 | 6 | int:PTPRK | |
| Interaction | PMCH interactions | 3.09e-04 | 26 | 103 | 3 | int:PMCH | |
| Interaction | OIT3 interactions | 3.43e-04 | 65 | 103 | 4 | int:OIT3 | |
| Interaction | DNAJC10 interactions | 3.79e-04 | 260 | 103 | 7 | int:DNAJC10 | |
| Interaction | LTBP4 interactions | 3.85e-04 | 67 | 103 | 4 | int:LTBP4 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr1q25 | 4.32e-05 | 167 | 105 | 5 | chr1q25 | |
| Cytoband | 6q22-q23 | 2.30e-04 | 10 | 105 | 2 | 6q22-q23 | |
| Cytoband | 12q13 | 5.93e-04 | 71 | 105 | 3 | 12q13 | |
| Cytoband | 19p13 | 1.75e-03 | 27 | 105 | 2 | 19p13 | |
| Cytoband | 1p32 | 1.75e-03 | 27 | 105 | 2 | 1p32 | |
| Cytoband | 1q25.3 | 2.31e-03 | 31 | 105 | 2 | 1q25.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19p13 | 2.43e-03 | 797 | 105 | 7 | chr19p13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 2.95e-03 | 423 | 105 | 5 | chr12q13 | |
| Cytoband | 7q22 | 3.45e-03 | 38 | 105 | 2 | 7q22 | |
| GeneFamily | Laminin subunits | 2.86e-20 | 12 | 71 | 9 | 626 | |
| GeneFamily | Low density lipoprotein receptors | 1.52e-07 | 13 | 71 | 4 | 634 | |
| GeneFamily | Latent transforming growth factor beta binding proteins | 9.08e-05 | 4 | 71 | 2 | 628 | |
| GeneFamily | Fibulins | 4.19e-04 | 8 | 71 | 2 | 556 | |
| GeneFamily | Ankyrin repeat domain containing | 2.62e-03 | 242 | 71 | 5 | 403 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 3.70e-03 | 161 | 71 | 4 | 593 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 5.01e-03 | 27 | 71 | 2 | 47 | |
| Coexpression | NABA_ECM_GLYCOPROTEINS | LAMB4 COMP EFEMP2 LAMA1 LAMA2 KCP LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 VWCE ECM1 VWDE SVEP1 NELL2 THBS2 THBS4 FBLN2 FBN2 SLIT3 LTBP2 LTBP3 USH2A AGRN FBN3 OTOG | 3.21e-36 | 196 | 103 | 28 | M3008 |
| Coexpression | NABA_MATRISOME | PCSK5 HGFAC LAMB4 ADAMTSL1 ADAM19 COMP FSTL3 ADAM15 EFEMP2 LAMA1 LAMA2 KCP LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 LGALS12 VWCE ECM1 VWDE ST14 SVEP1 NELL2 THBS2 THBS4 FBLN2 FBN2 PLXDC2 ADAMTS7 WFIKKN2 SLIT3 VWC2L LTBP2 LTBP3 USH2A AGRN MEGF11 FBN3 PLXNB3 IL9 OTOG | 2.70e-33 | 1026 | 103 | 43 | M5889 |
| Coexpression | NABA_CORE_MATRISOME | LAMB4 COMP EFEMP2 LAMA1 LAMA2 KCP LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 VWCE ECM1 VWDE SVEP1 NELL2 THBS2 THBS4 FBLN2 FBN2 SLIT3 LTBP2 LTBP3 USH2A AGRN FBN3 OTOG | 6.18e-32 | 275 | 103 | 28 | M5884 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | COMP EFEMP2 LAMA1 LAMA2 KCP LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 VWCE ECM1 VWDE SVEP1 NELL2 THBS2 THBS4 FBLN2 FBN2 SLIT3 LTBP2 LTBP3 AGRN OTOG | 2.51e-31 | 191 | 103 | 25 | MM17059 |
| Coexpression | NABA_MATRISOME | PCSK5 HGFAC ADAMTSL1 ADAM19 COMP FSTL3 ADAM15 EFEMP2 LAMA1 LAMA2 KCP LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 LGALS12 VWCE ECM1 VWDE ST14 SVEP1 NELL2 THBS2 THBS4 FBLN2 FBN2 PLXDC2 ADAMTS7 WFIKKN2 SLIT3 VWC2L LTBP2 LTBP3 AGRN MEGF11 PLXNB3 IL9 OTOG | 7.12e-30 | 1008 | 103 | 40 | MM17056 |
| Coexpression | NABA_CORE_MATRISOME | COMP EFEMP2 LAMA1 LAMA2 KCP LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 VWCE ECM1 VWDE SVEP1 NELL2 THBS2 THBS4 FBLN2 FBN2 SLIT3 LTBP2 LTBP3 AGRN OTOG | 1.88e-27 | 270 | 103 | 25 | MM17057 |
| Coexpression | NABA_BASEMENT_MEMBRANES | LAMB4 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC1 LAMC2 USH2A AGRN | 4.19e-18 | 40 | 103 | 11 | M5887 |
| Coexpression | HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION | COMP FSTL3 EFEMP2 LAMA1 LAMA2 LAMC1 LAMC2 ECM1 THBS2 FBLN2 FBN2 SLIT3 LRP1 NOTCH2 | 5.44e-14 | 200 | 103 | 14 | M5930 |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS | 3.04e-10 | 23 | 103 | 6 | M48001 | |
| Coexpression | NABA_MATRISOME_METASTATIC_COLORECTAL_LIVER_METASTASIS | 1.75e-09 | 30 | 103 | 6 | M47990 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_COLORECTAL_TUMOR | 3.39e-09 | 59 | 103 | 7 | M47989 | |
| Coexpression | NABA_MATRISOME_BLEO_FIBROTIC_LUNG | 1.26e-08 | 20 | 103 | 5 | MM17053 | |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | ADAM19 EFEMP2 LAMA5 LAMB2 LAMC1 ECM1 WDR35 LRP1 LTBP2 DKK3 NOTCH3 NOTCH4 PEAR1 | 9.55e-08 | 505 | 103 | 13 | M39167 |
| Coexpression | NABA_MATRISOME_HGSOC_OMENTAL_METASTASIS | 1.21e-07 | 59 | 103 | 6 | M47993 | |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 HGFAC ADAMTSL1 ADAM19 FSTL3 ADAM15 LGALS12 ST14 PLXDC2 ADAMTS7 WFIKKN2 VWC2L MEGF11 PLXNB3 IL9 | 1.98e-07 | 738 | 103 | 15 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | PCSK5 HGFAC ADAMTSL1 ADAM19 FSTL3 ADAM15 LGALS12 ST14 PLXDC2 ADAMTS7 WFIKKN2 VWC2L MEGF11 PLXNB3 IL9 | 2.47e-07 | 751 | 103 | 15 | M5885 |
| Coexpression | CERVERA_SDHB_TARGETS_2 | 3.64e-07 | 115 | 103 | 7 | M19068 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.95e-07 | 16 | 103 | 4 | MM1296 | |
| Coexpression | FUKUSHIMA_TNFSF11_TARGETS | 3.95e-07 | 16 | 103 | 4 | M2207 | |
| Coexpression | CUI_DEVELOPING_HEART_C3_FIBROBLAST_LIKE_CELL | 4.10e-07 | 117 | 103 | 7 | M39300 | |
| Coexpression | MOHANKUMAR_HOXA1_TARGETS_DN | 4.87e-07 | 176 | 103 | 8 | M9032 | |
| Coexpression | BOQUEST_STEM_CELL_UP | 9.31e-07 | 261 | 103 | 9 | M1834 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C7_MID_SCHWANN_CELL | 1.16e-06 | 268 | 103 | 9 | M45796 | |
| Coexpression | HEBERT_MATRISOME_TNBC_LUNG_METASTASIS_TUMOR_CELL_DERIVED | 1.17e-06 | 6 | 103 | 3 | M48000 | |
| Coexpression | GSE36888_STAT5_AB_KNOCKIN_VS_WT_TCELL_IL2_TREATED_2H_DN | 1.18e-06 | 198 | 103 | 8 | M8750 | |
| Coexpression | FAN_EMBRYONIC_CTX_BIG_GROUPS_BRAIN_ENDOTHELIAL | 1.81e-06 | 365 | 103 | 10 | M39018 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HPERIC | EFEMP2 LAMA2 KCP LAMB1 LAMB2 LAMC1 SVEP1 STAT6 LINGO1 JAG1 LRP1 AGRN NOTCH2 NOTCH3 | 2.82e-06 | 795 | 103 | 14 | M39050 |
| Coexpression | HU_FETAL_RETINA_FIBROBLAST | EFEMP2 LAMA1 LAMB1 LAMB2 LAMC1 FBN2 JAG1 NOTCH2 NOTCH3 PEAR1 | 2.92e-06 | 385 | 103 | 10 | M39264 |
| Coexpression | ATF2_S_UP.V1_DN | 9.35e-06 | 187 | 103 | 7 | M2681 | |
| Coexpression | DELYS_THYROID_CANCER_UP | 1.04e-05 | 445 | 103 | 10 | M3645 | |
| Coexpression | NABA_MATRISOME_PRIMARY_METASTATIC_LUNG_TUMOR | 1.07e-05 | 35 | 103 | 4 | MM17054 | |
| Coexpression | AIZARANI_LIVER_C21_STELLATE_CELLS_1 | 1.19e-05 | 194 | 103 | 7 | M39122 | |
| Coexpression | DEBIASI_APOPTOSIS_BY_REOVIRUS_INFECTION_DN | 1.37e-05 | 276 | 103 | 8 | M3063 | |
| Coexpression | NABA_MATRISOME_POORLY_METASTATIC_MELANOMA | 1.50e-05 | 38 | 103 | 4 | M47982 | |
| Coexpression | ROSS_AML_WITH_PML_RARA_FUSION | 1.62e-05 | 80 | 103 | 5 | M15368 | |
| Coexpression | DESCARTES_FETAL_THYMUS_STROMAL_CELLS | 1.72e-05 | 137 | 103 | 6 | M40313 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K4ME3_AND_H3K27ME3 | ERBB3 ENPP1 LAMA1 LAMB1 LAMC2 ST14 SVEP1 FBLN2 ADAMTS7 GJD3 JAG1 LRP2 LRP5 MEGF11 PEAR1 | 1.95e-05 | 1074 | 103 | 15 | M1941 |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 1.96e-05 | 479 | 103 | 10 | M2573 | |
| Coexpression | MEL18_DN.V1_UP | 2.03e-05 | 141 | 103 | 6 | M2784 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_UP | 2.10e-05 | 483 | 103 | 10 | MM1082 | |
| Coexpression | WANG_MLL_TARGETS | 2.15e-05 | 294 | 103 | 8 | M2456 | |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 2.67e-05 | 303 | 103 | 8 | M39040 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C1_MID_BASAL_CELL | 2.77e-05 | 149 | 103 | 6 | M45703 | |
| Coexpression | WANG_MLL_TARGETS | 2.87e-05 | 306 | 103 | 8 | MM1076 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 3.08e-05 | 225 | 103 | 7 | M6175 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_CLASSICAL | 4.28e-05 | 161 | 103 | 6 | M2121 | |
| Coexpression | CAIRO_LIVER_DEVELOPMENT_DN | 4.52e-05 | 239 | 103 | 7 | MM1274 | |
| Coexpression | VART_KSHV_INFECTION_ANGIOGENIC_MARKERS_UP | 4.58e-05 | 163 | 103 | 6 | M12112 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 5.42e-05 | 168 | 103 | 6 | M1124 | |
| Coexpression | GSE27859_MACROPHAGE_VS_CD11C_INT_F480_INT_DC_UP | 5.98e-05 | 171 | 103 | 6 | M8594 | |
| Coexpression | DING_LUNG_CANCER_BY_MUTATION_RATE | 6.40e-05 | 20 | 103 | 3 | M1189 | |
| Coexpression | SCHUETZ_BREAST_CANCER_DUCTAL_INVASIVE_UP | 7.67e-05 | 352 | 103 | 8 | M17471 | |
| Coexpression | MURARO_PANCREAS_MESENCHYMAL_STROMAL_CELL | ADAM19 LAMA2 LAMB1 LAMC1 THBS2 GJD3 JAG1 LTBP2 DKK3 NOTCH2 NOTCH3 | 7.68e-05 | 681 | 103 | 11 | M39175 |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 8.31e-05 | 569 | 103 | 10 | M12701 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 8.45e-05 | 182 | 103 | 6 | MM993 | |
| Coexpression | MEISSNER_BRAIN_HCP_WITH_H3K27ME3 | 1.27e-04 | 282 | 103 | 7 | MM822 | |
| Coexpression | GSE13522_WT_VS_IFNAR_KO_SKING_T_CRUZI_Y_STRAIN_INF_UP | 1.42e-04 | 200 | 103 | 6 | M2933 | |
| Coexpression | GSE37301_HEMATOPOIETIC_STEM_CELL_VS_COMMON_LYMPHOID_PROGENITOR_DN | 1.42e-04 | 200 | 103 | 6 | M8877 | |
| Coexpression | GSE2405_S_AUREUS_VS_A_PHAGOCYTOPHILUM_NEUTROPHIL_UP | 1.42e-04 | 200 | 103 | 6 | M6207 | |
| Coexpression | HEBERT_MATRISOME_TNBC_BRAIN_METASTASIS | 1.43e-04 | 26 | 103 | 3 | M47999 | |
| Coexpression | HARALAMBIEVA_PBMC_M_M_R_II_AGE_11_22YO_VACCINATED_VS_UNVACCINATED_7YR_DN | ERBB3 ADAM15 LAMB3 ST14 STAB1 PLXDC2 ADAMTS7 LRP1 LRP5 LTBP2 NOTCH3 | 1.59e-04 | 740 | 103 | 11 | M41202 |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 1.61e-04 | 27 | 103 | 3 | M1391 | |
| Coexpression | DI_MARTINO_MATRISOME_HIGHLY_PROLIFERATIVE_HNSCC | 1.61e-04 | 27 | 103 | 3 | M47994 | |
| Coexpression | SHIN_B_CELL_LYMPHOMA_CLUSTER_7 | 1.61e-04 | 27 | 103 | 3 | MM1135 | |
| Coexpression | GAO_ESOPHAGUS_25W_C4_FGFR1HIGH_EPITHELIAL_CELLS | 1.75e-04 | 208 | 103 | 6 | M39139 | |
| Coexpression | GU_PDEF_TARGETS_UP | 1.79e-04 | 71 | 103 | 4 | M3955 | |
| Coexpression | MARTINEZ_RB1_TARGETS_DN | 1.90e-04 | 630 | 103 | 10 | MM1038 | |
| Coexpression | CAIRO_HEPATOBLASTOMA_CLASSES_DN | 1.99e-04 | 213 | 103 | 6 | M12176 | |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER_TUMOR_CELL_DERIVED | 2.00e-04 | 29 | 103 | 3 | M47987 | |
| Coexpression | NABA_MATRISOME_METASTATIC_LUNG_LYMPH_NODE_METASTASIS | 2.00e-04 | 29 | 103 | 3 | MM17055 | |
| Coexpression | TURASHVILI_BREAST_LOBULAR_CARCINOMA_VS_LOBULAR_NORMAL_DN | 2.09e-04 | 74 | 103 | 4 | M13547 | |
| Coexpression | GSE9946_MATURE_STIMULATORY_VS_PROSTAGLANDINE2_TREATED_MATURE_DC_DN | 2.11e-04 | 137 | 103 | 5 | M429 | |
| Coexpression | VERHAAK_GLIOBLASTOMA_MESENCHYMAL | 2.15e-04 | 216 | 103 | 6 | M2122 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | FAT3 EFEMP2 LAMB2 LAMC1 SVEP1 THBS2 LINGO1 JAG1 SLIT3 LTBP2 NOTCH3 | 2.17e-04 | 767 | 103 | 11 | M39209 |
| Coexpression | FRASOR_RESPONSE_TO_ESTRADIOL_DN | 2.57e-04 | 78 | 103 | 4 | M3002 | |
| Coexpression | HALLMARK_NOTCH_SIGNALING | 2.69e-04 | 32 | 103 | 3 | M5903 | |
| Coexpression | BMI1_DN.V1_UP | 2.92e-04 | 147 | 103 | 5 | M2782 | |
| Coexpression | WEST_ADRENOCORTICAL_TUMOR_DN | 3.06e-04 | 546 | 103 | 9 | M3837 | |
| Coexpression | RIGGI_EWING_SARCOMA_PROGENITOR_UP | 3.35e-04 | 437 | 103 | 8 | M15981 | |
| Coexpression | LIU_CDX2_TARGETS_UP | 3.52e-04 | 35 | 103 | 3 | M16637 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | ADAM19 EFEMP2 LAMA2 IER5 SVEP1 STAB1 THBS2 FBLN2 PLXDC2 DENND4B LTBP2 LTBP3 ADGRE1 PLXNB3 | 3.57e-04 | 1242 | 103 | 14 | M1920 |
| Coexpression | NABA_ECM_REGULATORS | 3.61e-04 | 238 | 103 | 6 | M3468 | |
| Coexpression | NABA_ECM_REGULATORS | 3.95e-04 | 242 | 103 | 6 | MM17062 | |
| Coexpression | BRUNEAU_HEART_GREAT_VESSELS_AND_VALVULOGENESIS | 4.22e-04 | 8 | 103 | 2 | M9884 | |
| Coexpression | DESCARTES_FETAL_LIVER_STELLATE_CELLS | 4.31e-04 | 160 | 103 | 5 | M40233 | |
| Coexpression | SMID_BREAST_CANCER_BASAL_DN | 4.33e-04 | 699 | 103 | 10 | M4960 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL3 | 4.40e-04 | 574 | 103 | 9 | M39056 | |
| Coexpression | CARRILLOREIXACH_HEPATOBLASTOMA_VS_NORMAL_HYPOMETHYLATED_AND_UP | 4.56e-04 | 162 | 103 | 5 | M45037 | |
| Coexpression | PETROVA_ENDOTHELIUM_LYMPHATIC_VS_BLOOD_DN | 4.56e-04 | 162 | 103 | 5 | M1459 | |
| Coexpression | YAMAZAKI_TCEB3_TARGETS_UP | 5.09e-04 | 166 | 103 | 5 | M1542 | |
| Coexpression | WONG_ADULT_TISSUE_STEM_MODULE | LAMA2 LAMB1 LAMC1 THBS4 FBLN2 PLXDC2 LTBP2 LTBP3 ADGRE1 DKK3 | 5.51e-04 | 721 | 103 | 10 | M1999 |
| Coexpression | NABA_MATRISOME_HIGHLY_METASTATIC_BREAST_CANCER | 5.64e-04 | 41 | 103 | 3 | M47988 | |
| Coexpression | RIZKI_TUMOR_INVASIVENESS_3D_DN | 5.99e-04 | 262 | 103 | 6 | M11472 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 6.05e-04 | 600 | 103 | 9 | M39055 | |
| Coexpression | DELACROIX_RARG_BOUND_MEF | 6.15e-04 | 366 | 103 | 7 | M2461 | |
| Coexpression | CHEN_METABOLIC_SYNDROM_NETWORK | ADAM19 EFEMP2 LAMA2 IER5 SVEP1 STAB1 THBS2 FBLN2 PLXDC2 DENND4B LTBP2 LTBP3 ADGRE1 PLXNB3 | 6.34e-04 | 1316 | 103 | 14 | MM1052 |
| Coexpression | BROWNE_HCMV_INFECTION_48HR_DN | 6.38e-04 | 482 | 103 | 8 | M12144 | |
| Coexpression | DESCARTES_ORGANOGENESIS_EPITHELIAL_CELLS | 6.47e-04 | 175 | 103 | 5 | MM3643 | |
| Coexpression | ROZANOV_MMP14_TARGETS_UP | 6.62e-04 | 267 | 103 | 6 | M12890 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_DN | 6.80e-04 | 610 | 103 | 9 | M3854 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | LAMA2 LAMB1 LAMB2 LAMC1 DLK1 ECM1 SVEP1 ADH7 THBS2 THBS4 FBLN2 PLXDC2 SLIT3 LRP1 | 2.58e-08 | 437 | 103 | 14 | GSM777046_500 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | EFEMP2 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 THBS2 PLXDC2 JAG1 SLIT3 LRP1 NOTCH3 | 4.04e-08 | 453 | 103 | 14 | GSM777067_500 |
| CoexpressionAtlas | Stromal Cells, FRC.MLN, gp38+ CD31- CD140a+, Lymph Node, avg-5 | EFEMP2 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 THBS2 PLXDC2 SLIT3 LRP1 LTBP3 NOTCH3 | 5.73e-08 | 466 | 103 | 14 | GSM777050_500 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 | PCSK5 PLAC1 ADAMTSL1 FSTL3 EFEMP2 KCP LAMB2 MIB2 ZNF428 KIAA1614 SVEP1 LRFN4 FBLN2 FBN2 LINGO1 PRICKLE3 DENND4B SLIT3 LRP1 LRP5 LTBP3 DKK3 | 8.15e-08 | 1228 | 103 | 22 | facebase_RNAseq_e14.5_palate_poster_nasal_Tgfbr2_WT_2500_K2 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#3_top-relative-expression-ranked_1000 | FAT3 LAMA1 LAMA5 LAMC1 LAMC2 JAG1 SLIT3 AGRN NOTCH2 NOTCH3 HDC | 1.85e-07 | 293 | 103 | 11 | gudmap_kidney_P0_JuxtaGlom_Ren1_k3_1000 |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | LAMA2 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 PLA1A JAG1 SLIT3 LRP1 | 2.44e-07 | 445 | 103 | 13 | GSM777043_500 |
| CoexpressionAtlas | Stromal Cells, FRC.SLN, gp38+ CD31- CD140a+, Lymph Node, avg-4 | EFEMP2 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 THBS2 PLXDC2 JAG1 SLIT3 LRP1 LTBP2 NOTCH3 | 3.14e-07 | 455 | 103 | 13 | GSM777055_500 |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 | MPO PCSK5 PLAC1 ADAMTSL1 ENPP1 EFEMP2 LAMA2 KCP IER5 KIAA1614 SVEP1 THBS2 FBLN2 FBN2 LINGO1 ADAMTS7 SLIT3 LTBP3 DKK3 HDC | 5.46e-07 | 1148 | 103 | 20 | facebase_RNAseq_e14.5_palate_poster_oral_Tgfbr2_WT_2500_K4 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_1000 | ADAMTSL1 FAT3 LAMA1 LAMA5 LAMB2 LAMC1 LAMC2 ECM1 THBS4 AFM JAG1 SLIT3 LRP2 AGRN NOTCH2 NOTCH3 HDC | 1.59e-06 | 905 | 103 | 17 | gudmap_kidney_P0_JuxtaGlom_Ren1_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#3_top-relative-expression-ranked_200 | 1.80e-06 | 42 | 103 | 5 | gudmap_developingKidney_e15.5_early proxim tubul_200_k3 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 2.71e-06 | 310 | 103 | 10 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | PCSK5 ADAM19 FAT3 EFEMP2 LAMA1 LAMA2 LAMB1 DLK1 SVEP1 FBLN2 FBN2 PLXDC2 JAG1 LRP1 NOTCH2 | 4.38e-06 | 768 | 103 | 15 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | PCSK5 ADAMTSL1 ADAM19 FAT3 EFEMP2 LAMA1 LAMA2 LAMB1 DLK1 SVEP1 FBN2 PLXDC2 JAG1 LRP1 NOTCH2 | 5.04e-06 | 777 | 103 | 15 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_1000 | ADAMTSL1 FAT3 LAMA2 LAMB2 ECM1 SVEP1 THBS4 FBLN2 PLXDC2 LRP1 LRP2 LTBP2 LYNX1 LTBP3 ADGRE1 | 5.12e-06 | 778 | 103 | 15 | gudmap_kidney_adult_RenalCapsule_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.11e-05 | 156 | 103 | 7 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#2_top-relative-expression-ranked_1000 | ADAMTSL1 LAMA2 SVEP1 THBS4 FBLN2 LRP1 LTBP2 LYNX1 LTBP3 ADGRE1 | 1.25e-05 | 369 | 103 | 10 | gudmap_kidney_adult_RenalCapsule_k2_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_500 | 1.60e-05 | 165 | 103 | 7 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000 | MPO ADAMTSL1 KCP LAMA5 DLK1 KEAP1 STAB1 NELL2 THBS2 LRFN4 FBLN2 WFIKKN2 WDR35 TRPM1 LTBP3 AGRN | 1.79e-05 | 974 | 103 | 16 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_500 | 1.97e-05 | 389 | 103 | 10 | gudmap_developingKidney_e15.5_Proximal Tubules_500 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | ADAM19 FAT3 EFEMP2 LAMA1 LAMA2 LAMB1 DLK1 SVEP1 FBN2 PLXDC2 JAG1 LRP1 LYNX1 NOTCH2 | 2.18e-05 | 773 | 103 | 14 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_1000_k-means-cluster#4 | 2.31e-05 | 241 | 103 | 8 | Facebase_RNAseq_ratio_e10.5_MandibularArch_vs_MaxillaryArch_1000_K4 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_top-relative-expression-ranked_500 | ADAMTSL1 LAMA2 ECM1 SVEP1 THBS4 PLXDC2 LRP1 LRP2 LYNX1 ADGRE1 | 2.96e-05 | 408 | 103 | 10 | gudmap_kidney_adult_RenalCapsule_500 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.80e-05 | 336 | 103 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k3_1000 | |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | ADAM15 LAMA1 LAMA5 LAMB1 DLK1 MIB2 ZNF428 AHDC1 NELL2 THBS4 ADAMTS7 JAG1 LRP2 LTBP2 AGRN NOTCH2 | 5.88e-05 | 1075 | 103 | 16 | PCBC_ratio_ECTO_vs_DE_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 5.94e-05 | 356 | 103 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#5_top-relative-expression-ranked_1000 | 6.66e-05 | 280 | 103 | 8 | gudmap_developingKidney_e15.5_Proximal Tubules_1000_k5 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 | PLAC1 ADAMTSL1 FSTL3 ADAM15 FAT3 LAMA2 KCP KIAA1614 SVEP1 STAB1 THBS2 FBLN2 FBN2 LINGO1 ADAMTS7 LRP1 DKK3 | 6.75e-05 | 1208 | 103 | 17 | facebase_RNAseq_e14.5_palate_poster_proximal_ERK2_WT_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000 | ADAMTSL1 LAMA2 KCP LGALS12 DLK1 MIB2 NELL2 THBS2 FBLN2 ADAMTS7 PRICKLE3 DENND4B WFIKKN2 LTBP2 LTBP3 | 6.93e-05 | 973 | 103 | 15 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000 |
| CoexpressionAtlas | Ectoderm Differentiated Cells_vs_Pluripotent Stem Cells-Confounder_removed-fold2.0_adjp0.05 | ADAM19 EFEMP2 LAMA1 LAMB1 LAMB2 DLK1 MIB2 ZNF428 ZFC3H1 AHDC1 NELL2 THBS4 FBN2 JAG1 LRP2 LTBP2 AGRN FBN3 NOTCH2 | 7.23e-05 | 1466 | 103 | 19 | PCBC_ratio_ECTO_vs_SC_cfr-2X-p05 |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | ADAM15 LAMA5 LAMB1 LAMB2 LAMC1 STAB1 FBLN2 JAG1 LTBP2 NOTCH4 | 7.51e-05 | 456 | 103 | 10 | GSM777032_500 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_top-relative-expression-ranked_500 | 7.51e-05 | 456 | 103 | 10 | gudmap_kidney_P0_JuxtaGlom_Ren1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_1000 | ERBB3 LAMA1 LAMB1 LGALS12 ZFC3H1 VWCE PLA1A AFM JAG1 LRP2 C8A AGRN HDC | 7.66e-05 | 758 | 103 | 13 | gudmap_developingKidney_e15.5_Proximal Tubules_1000 |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | ADAM19 EFEMP2 LAMA1 KCP LAMB1 LAMB3 LGALS12 DLK1 ECM1 FBLN2 FBN2 PLA1A LTBP2 LTBP3 HDC | 7.69e-05 | 982 | 103 | 15 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | ADAM15 LAMA5 LAMB1 LAMB2 LAMC1 STAB1 FBLN2 JAG1 LTBP2 NOTCH4 | 7.93e-05 | 459 | 103 | 10 | GSM777037_500 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_top-relative-expression-ranked_200 | 8.82e-05 | 149 | 103 | 6 | gudmap_developingKidney_e15.5_Proximal Tubules_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_200 | 9.49e-05 | 151 | 103 | 6 | gudmap_developingKidney_e15.5_early proxim tubul_200 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_1000 | FAT3 LAMA1 LAMA5 LAMB1 LAMC1 LAMC2 ST14 NELL2 FBN2 JAG1 LRP2 AGRN NOTCH2 | 1.06e-04 | 783 | 103 | 13 | gudmap_kidney_P4_CapMesRenVes_Crym_1000 |
| CoexpressionAtlas | kidney_P0_JuxtaGlom_Ren1_k-means-cluster#4_top-relative-expression-ranked_500 | 1.10e-04 | 155 | 103 | 6 | gudmap_kidney_P0_JuxtaGlom_Ren1_k4_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | PCSK5 PLAC1 ADAM19 FAT3 LAMA1 LAMA2 LAMB1 DLK1 SVEP1 FBLN2 PLXDC2 LRP1 NOTCH2 | 1.20e-04 | 793 | 103 | 13 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | PCSK5 ADAMTSL1 ENPP1 FAT3 LAMA2 DLK1 RLF THBS2 FBLN2 SLIT3 WDR35 LRP1 LTBP2 | 1.30e-04 | 799 | 103 | 13 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | PCSK5 ZNF142 ENPP1 FAT3 LAMB1 DLK1 ECM1 SVEP1 RLF FBLN2 WDR35 LRP1 ADGRE1 | 1.33e-04 | 801 | 103 | 13 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_top-relative-expression-ranked_500 | 1.39e-04 | 398 | 103 | 9 | gudmap_kidney_P4_CapMesRenVes_Crym_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_top-relative-expression-ranked_1000 | ERBB3 FAT3 LAMB3 LAMC1 IER5 ST14 THBS4 ADAMTS7 FAM161A AGRN MEGF11 DKK3 HDC | 1.41e-04 | 806 | 103 | 13 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#4_top-relative-expression-ranked_500 | 1.53e-04 | 104 | 103 | 5 | gudmap_developingKidney_e15.5_early proxim tubul_500_k4 | |
| CoexpressionAtlas | Mesoderm Day 15_vs_Mesoderm Day 5-Confounder_removed-fold2.0_adjp0.05 | PCSK5 ERBB3 LAMB1 LAMB2 LAMB3 LAMC1 DLK1 VWCE TYK2 PLXDC2 JAG1 SLIT3 LRP1 LRP2 LTBP3 | 1.59e-04 | 1049 | 103 | 15 | PCBC_ratio_MESO-15_vs_MESO-5_cfr-2X-p05 |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_top-relative-expression-ranked_200 | 1.59e-04 | 166 | 103 | 6 | gudmap_kidney_P3_CapMes_Crym_200 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urethra_emap-30892_k-means-cluster#5_top-relative-expression-ranked_1000 | 1.83e-04 | 108 | 103 | 5 | gudmap_developingLowerUrinaryTract_e14.5_ urethra_1000_k5 | |
| CoexpressionAtlas | kidney_P4_CapMesRenVes_Crym_k-means-cluster#3_top-relative-expression-ranked_200 | 2.35e-04 | 62 | 103 | 4 | gudmap_kidney_P4_CapMesRenVes_Crym_k3_200 | |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | HGFAC ADAMTSL1 ADAM19 EFEMP2 OR8S1 KCP DLK1 ECM1 LRP1B SVEP1 FBLN2 FBN2 SLIT3 LRP2 LTBP2 | 2.51e-04 | 1094 | 103 | 15 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.53e-04 | 256 | 103 | 7 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 2.62e-04 | 182 | 103 | 6 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | kidney_P3_CapMes_Crym_k-means-cluster#4_top-relative-expression-ranked_200 | 2.82e-04 | 65 | 103 | 4 | gudmap_kidney_P3_CapMes_Crym_k4_200 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_k-means-cluster#2_top-relative-expression-ranked_100 | 2.98e-04 | 27 | 103 | 3 | gudmap_developingKidney_e15.5_early proxim tubul_100_k2 | |
| CoexpressionAtlas | placenta | 3.01e-04 | 349 | 103 | 8 | placenta | |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 3.11e-04 | 265 | 103 | 7 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC-Confounder_removed-fold2.0_adjp0.05 | PCSK5 ERBB3 ADAM19 FSTL3 LAMB1 LAMB3 LAMC1 LAMC2 ST14 SLIT3 LTBP2 C6 | 3.18e-04 | 761 | 103 | 12 | PCBC_ratio_MESO-30 blastocyst_vs_MESO-30 amniotic fluid MSC_cfr-2X-p05 |
| CoexpressionAtlas | dev gonad_e11.5_F_GonadVasMes_Flk_k-means-cluster#3_top-relative-expression-ranked_1000 | 3.31e-04 | 354 | 103 | 8 | gudmap_dev gonad_e11.5_F_GonadVasMes_Flk_k3_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k-means-cluster#4_top-relative-expression-ranked_1000 | 3.60e-04 | 125 | 103 | 5 | gudmap_dev gonad_e12.5_F_VasAssocMesStromOvary_Sma_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_B_emap-30374_top-relative-expression-ranked_1000 | ADAMTSL1 FSTL3 ENPP1 LAMB1 LAMB3 LAMC1 LAMC2 DLK1 ADH7 THBS2 TSPAN17 PLA1A | 3.70e-04 | 774 | 103 | 12 | gudmap_developingLowerUrinaryTract_P1_bladder_1000_B |
| CoexpressionAtlas | JC_hmvEC_top-relative-expression-ranked_2500_k-means-cluster#3 | 3.84e-04 | 362 | 103 | 8 | JC_hmvEC_2500_K3 | |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Podocytes_2500_K0 | MPO PLAC1 ADAM15 EFEMP2 LAMC1 ZNF428 KIAA1614 STAB1 LRFN4 FBLN2 LINGO1 SLIT3 MEGF11 DKK3 NOTCH4 | 4.00e-04 | 1143 | 103 | 15 | gudmap_RNAseq_e15.5_Podocytes_2500_K0 |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_top-relative-expression-ranked_500 | 4.23e-04 | 463 | 103 | 9 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_500 | |
| CoexpressionAtlas | JC_fibro_top-relative-expression-ranked_1000_k-means-cluster#1 | 4.30e-04 | 464 | 103 | 9 | JC_fibro_1000_K1 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e14.5_ urogenital sinus_emap-5517_k-means-cluster#2_top-relative-expression-ranked_1000 | 4.40e-04 | 73 | 103 | 4 | gudmap_developingLowerUrinaryTract_e14.5_ urogenital sinus_1000_k2 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | PCSK5 ZNF142 ENPP1 FAT3 DLK1 ECM1 SVEP1 RLF FBLN2 FBN2 LRP1 ADGRE1 | 4.45e-04 | 790 | 103 | 12 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_top-relative-expression-ranked_1000_k-means-cluster#4 | 4.82e-04 | 204 | 103 | 6 | Facebase_RNAseq_ratio_e10.5_MaxillaryArch_vs_Mandibular_1000_K4 | |
| CoexpressionAtlas | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 | MPO PCSK5 ADAMTSL1 FAT3 LAMA2 KCP SVEP1 STAB1 THBS2 FBLN2 FBN2 LINGO1 PLXDC2 SLIT3 DKK3 | 4.93e-04 | 1166 | 103 | 15 | facebase_RNAseq_e14.5_palate_poster_distal_ERK2_WT_2500_K1 |
| CoexpressionAtlas | gudmap_RNAseq_e15.5_Mesangium_2500_K2 | PCSK5 ADAMTSL1 ADAM19 FSTL3 EFEMP2 LAMA2 KCP IER5 ZNF428 SVEP1 THBS2 FBN2 LINGO1 SLIT3 LTBP3 DKK3 | 5.03e-04 | 1298 | 103 | 16 | gudmap_RNAseq_e15.5_Mesangium_2500_K2 |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Maxillary Arch_top-relative-expression-ranked_500_k-means-cluster#3 | 5.48e-04 | 137 | 103 | 5 | Facebase_RNAseq_e9.5_Maxillary Arch_500_K3 | |
| CoexpressionAtlas | DevelopingKidney_e14.5 whole kidney - wildtype_emap-6674_top-relative-expression-ranked_100 | 5.65e-04 | 78 | 103 | 4 | gudmap_developingKidney_e14.5 whole kidney - wildtype_emap-6674_100 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II+480int.PC, CD115+ MHC II+ F480lo SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 6.22e-04 | 80 | 103 | 4 | GSM605856_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_top-relative-expression-ranked_500 | 6.28e-04 | 390 | 103 | 8 | gudmap_developingKidney_e15.5_cortic collect duct_500 | |
| CoexpressionAtlas | Myeloid Cells, MF.Thio5.II-480int.PC, CD115+ MHCII- F480int SiglecF- CD11c+, Peritoneal Cavity, avg-3 | 6.52e-04 | 81 | 103 | 4 | GSM605865_100 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_early proxim tubul_emap-28005_top-relative-expression-ranked_500 | 6.60e-04 | 393 | 103 | 8 | gudmap_developingKidney_e15.5_early proxim tubul_500 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_top-relative-expression-ranked_1000 | ADAM19 FAT3 LAMA1 DLK1 ECM1 ZBTB1 SVEP1 FBLN2 FBN2 WDR35 LRP1 NOTCH2 | 6.67e-04 | 827 | 103 | 12 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_1000 |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_e15.5_Urothelium_emap-28091_top-relative-expression-ranked_500 | 6.71e-04 | 394 | 103 | 8 | gudmap_developingLowerUrinaryTract_e15.5_urothelium_500 | |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | ADAMTSL1 ENPP1 LAMA1 DLK1 ECM1 SVEP1 NELL2 THBS2 SLIT3 LRP2 TRPM1 LTBP2 FBN3 | 6.89e-04 | 951 | 103 | 13 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_M_DevVasTestis_Flk_k-means-cluster#4_top-relative-expression-ranked_1000 | 7.78e-04 | 148 | 103 | 5 | gudmap_dev gonad_e13.5_M_gudmap_devVasTestis_Flk_k4_1000 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P1_bladder_J_emap-30374_k-means-cluster#1_top-relative-expression-ranked_1000 | 8.02e-04 | 149 | 103 | 5 | gudmap_developingLowerUrinaryTract_P1_bladder_J_1000_k1 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 8.17e-04 | 86 | 103 | 4 | GSM605850_100 | |
| CoexpressionAtlas | MESO-5 blastocyst_vs_MESO-5 bone marrow-Confounder_removed-fold2.0_adjp0.05 | 8.17e-04 | 86 | 103 | 4 | PCBC_ratio_MESO-5 blastocyst_vs_MESO-5 bone marrow_cfr-2X-p05 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000 | ERBB3 ADAMTSL1 KCP LAMA5 LGALS12 DLK1 ST14 NELL2 THBS2 FBLN2 WFIKKN2 LRP2 LTBP3 | 8.51e-04 | 973 | 103 | 13 | Facebase_RNAseq_e9.5_Olfactory Placode_1000 |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_reference_CardiacMyocyte_top-relative-expression-ranked_1000 | ADAMTSL1 EFEMP2 LAMA1 LAMB3 LAMC1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LRP1 LTBP2 DKK3 | 8.67e-04 | 975 | 103 | 13 | PCBC_ctl_CardiacMyocyte_1000 |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | ADAMTSL1 ENPP1 FAT3 LAMA2 DLK1 SVEP1 NELL2 THBS2 TSPAN17 FBN2 SLIT3 | 8.68e-04 | 734 | 103 | 11 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#1_top-relative-expression-ranked_200 | 8.92e-04 | 39 | 103 | 3 | gudmap_developingKidney_e15.5_Proximal Tubules_200_k1 | |
| CoexpressionAtlas | Mesoderm Day 5_vs_Endoderm Differentiated Cells-Confounder_removed-fold2.0_adjp0.05 | 9.52e-04 | 320 | 103 | 7 | PCBC_ratio_MESO-5_vs_DE_cfr-2X-p05 | |
| CoexpressionAtlas | Mesoderm Day 30_vs_Mesoderm Day 15-Confounder_removed-fold2.0_adjp0.05 | 9.61e-04 | 40 | 103 | 3 | PCBC_ratio_MESO-30_vs_MESO-15_cfr-2X-p05 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_k-means-cluster#5_top-relative-expression-ranked_1000 | 9.87e-04 | 234 | 103 | 6 | gudmap_developingGonad_e18.5_epididymis_1000_k5 | |
| CoexpressionAtlas | dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_500 | 1.01e-03 | 157 | 103 | 5 | gudmap_dev lower uro neuro_e14.5_PelvicGanglion_Sox10_k4_500 | |
| CoexpressionAtlas | FacebaseRNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_top-relative-expression-ranked_2500_k-means-cluster#1 | 1.01e-03 | 420 | 103 | 8 | Facebase_RNAseq_ratio_e9.5_MandibularArch_vs_MaxillaryArch_2500_K1 | |
| CoexpressionAtlas | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | 1.11e-03 | 426 | 103 | 8 | mendel_RNAseq_e18.5_Urothelium_Krt5CreRFP_2500_K2 | |
| CoexpressionAtlas | kidney_adult_RenalCapsule_k-means-cluster#1_top-relative-expression-ranked_500 | 1.12e-03 | 240 | 103 | 6 | gudmap_kidney_adult_RenalCapsule_k1_500 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_Proximal Tubules_emap-28005_k-means-cluster#4_top-relative-expression-ranked_500 | 1.19e-03 | 95 | 103 | 4 | gudmap_developingKidney_e15.5_Proximal Tubules_500_k4 | |
| CoexpressionAtlas | FacebaseRNAseq_e9.5_Olfactory Placode_top-relative-expression-ranked_1000_k-means-cluster#5 | 1.22e-03 | 244 | 103 | 6 | Facebase_RNAseq_e9.5_Olfactory Placode_1000_K5 | |
| CoexpressionAtlas | DevelopingKidney_e15.5_cortic collect duct_emap-28132_k-means-cluster#2_top-relative-expression-ranked_100 | 1.25e-03 | 11 | 103 | 2 | gudmap_developingKidney_e15.5_cortic collect duct_100_k2 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.28e-03 | 97 | 103 | 4 | GSM777043_100 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 1.28e-03 | 97 | 103 | 4 | GSM777046_100 | |
| CoexpressionAtlas | dev gonad_e11.5_M_GonadVasMes_Flk_k-means-cluster#1_top-relative-expression-ranked_1000 | 1.28e-03 | 337 | 103 | 7 | gudmap_dev gonad_e11.5_M_GonadVasMes_Flk_k1_1000 | |
| CoexpressionAtlas | Myeloid Cells, MF.II-480hi.PC, F4/80hi CD115hi CD11b+ MHC II- CD11c-, Peritoneal Cavity, avg-3 | 1.32e-03 | 438 | 103 | 8 | GSM605850_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 1.34e-03 | 439 | 103 | 8 | GSM777059_500 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB2 LAMC1 ECM1 SVEP1 THBS2 THBS4 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 LTBP3 | 2.89e-17 | 193 | 105 | 14 | 45b5cab4dfeb0ed3b13631db5963740a792b810f |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | COMP EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LRP1 LTBP2 DKK3 | 1.25e-15 | 195 | 105 | 13 | 1236dc60288c7dd91868e86e9174a2dacd3b11b3 |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 2.95e-14 | 189 | 105 | 12 | bc54ffd7bd1627a36747a80ce5139e4a69928400 |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 3.14e-14 | 190 | 105 | 12 | f3ca94a31a35eed5fecf3c4b8c957e1bc4150158 |
| ToppCell | droplet-Mammary_Gland-nan-21m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 3.14e-14 | 190 | 105 | 12 | c2cd1eb674162ee40502c3380b7245c85079c7ce |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMC1 ECM1 SVEP1 THBS2 THBS4 PLXDC2 PLA1A SLIT3 LRP1 LTBP3 | 3.79e-14 | 193 | 105 | 12 | 49600db68ed65cafc67bd45a285b364e4f5f88af |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LRP1 LTBP2 | 5.80e-14 | 200 | 105 | 12 | 933b5b400e48a511ba0a056be1d33d3610b5f10d |
| ToppCell | Parenchymal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FSTL3 EFEMP2 LAMA2 LAMB1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LTBP2 DKK3 NOTCH3 | 5.80e-14 | 200 | 105 | 12 | 2e525c0d9684e7a2275edb04e1addb6fc6a872e5 |
| ToppCell | Parenchymal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | FSTL3 EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 FBLN2 SLIT3 LRP1 LTBP2 DKK3 | 5.80e-14 | 200 | 105 | 12 | f6be0f24e607abb9007823a54fb0b24d04990a89 |
| ToppCell | Biopsy_Other_PF-Mesenchymal|Biopsy_Other_PF / Sample group, Lineage and Cell type | FSTL3 EFEMP2 LAMA2 LAMB1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LTBP2 DKK3 NOTCH3 | 5.80e-14 | 200 | 105 | 12 | d6fcdd48858b53b5a8d18ae14b2dc4d9af41b070 |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 ECM1 SVEP1 FBLN2 FBN2 PLXDC2 PLA1A SLIT3 LRP2 | 8.43e-13 | 187 | 105 | 11 | 4e553721fa5598cb211f44e3226280b7e6885484 |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 ECM1 SVEP1 FBLN2 FBN2 PLXDC2 PLA1A SLIT3 LRP2 | 8.43e-13 | 187 | 105 | 11 | d36e7fc6125e7a4310499365022d38f34b757a73 |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 ECM1 SVEP1 FBLN2 FBN2 PLXDC2 PLA1A SLIT3 LRP2 | 8.43e-13 | 187 | 105 | 11 | 827eae63fabf6892a82ce7779b5f395958d3d628 |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast-adventitial_fibroblast_l1|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ADAMTSL1 EFEMP2 LAMA2 LAMB1 LAMC1 SVEP1 ADH7 FBLN2 PLXDC2 SLIT3 LRP1 | 1.13e-12 | 192 | 105 | 11 | 7b48df661f61ce494bf6f0b9a74b0422e29c24bf |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 FBLN2 PLXDC2 SLIT3 LRP1 | 1.13e-12 | 192 | 105 | 11 | beac6b3c191b11add8e39e8d04562b478ea8929e |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-nan|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 1.13e-12 | 192 | 105 | 11 | 2d9e2262f1342fe17735f21f733c029d1275e955 |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK5 LAMA2 LAMB1 LAMC1 SVEP1 FBLN2 PLXDC2 SLIT3 LRP1 LTBP3 DKK3 | 1.19e-12 | 193 | 105 | 11 | ebd090d7801480b3cee45caac3d30cc991836769 |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK5 LAMA2 LAMB1 LAMC1 SVEP1 FBLN2 PLXDC2 SLIT3 LRP1 LTBP3 DKK3 | 1.19e-12 | 193 | 105 | 11 | 22c58032e58730715224d7934968ce92d150b0e8 |
| ToppCell | droplet-Fat-Mat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK5 LAMA2 LAMB1 LAMC1 SVEP1 FBLN2 PLXDC2 SLIT3 LRP1 LTBP3 DKK3 | 1.19e-12 | 193 | 105 | 11 | 573ad2f848bede1fe20c7b4b352a9242ec294725 |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 1.26e-12 | 194 | 105 | 11 | f906b090f67df4cfe3498cdbb52cc0efa08e06cc |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 1.26e-12 | 194 | 105 | 11 | 944cdb0403d80a10a2eea2a3516a9343dbccc32c |
| ToppCell | facs-MAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 1.26e-12 | 194 | 105 | 11 | 85081d255fcc1e9854c0073321dd9f0feaa48866 |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK5 ADAMTSL1 EFEMP2 LAMA2 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 SLIT3 LTBP3 | 1.33e-12 | 195 | 105 | 11 | 69a29d03e664b72f32d41876510c62345c3aed31 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PCSK5 ADAMTSL1 LAMA2 LAMC1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LRP1 LTBP2 | 1.33e-12 | 195 | 105 | 11 | f54bc4454270ff06e85596f98199372b50d0179f |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK5 ADAMTSL1 EFEMP2 LAMA2 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 SLIT3 LTBP3 | 1.33e-12 | 195 | 105 | 11 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | PCSK5 ADAMTSL1 EFEMP2 LAMA2 LAMB1 LAMB2 LAMC1 ECM1 SVEP1 SLIT3 LTBP3 | 1.33e-12 | 195 | 105 | 11 | 9cef6f18664518060af7c192310dddce6d70345a |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 THBS2 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 1.41e-12 | 196 | 105 | 11 | 65f2f51e17f1869f3468813127b96d3048d8ad41 |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal-mesenchymal_progenitor|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 THBS2 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 1.41e-12 | 196 | 105 | 11 | e4ed897900a6472738bc6be2fb4817192727225d |
| ToppCell | facs-SCAT-Fat-18m-Mesenchymal|SCAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 THBS2 FBLN2 PLXDC2 PLA1A SLIT3 LRP1 | 1.41e-12 | 196 | 105 | 11 | 2cd83176f2e8a9e6fa3c08cb33928a61e5fc43b6 |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PCSK5 COMP LAMA2 LAMC1 ECM1 SVEP1 THBS2 THBS4 FBLN2 LRP1 LTBP2 | 1.49e-12 | 197 | 105 | 11 | 71786e9432e2d649f5d86f639abb25e7102deb67 |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | COMP INSRR LAMA2 LAMB1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LTBP2 DKK3 | 1.49e-12 | 197 | 105 | 11 | 44673c38384453207871d3fd8e8ba9093cc06bc5 |
| ToppCell | COVID-19-lung-Fibroblast|COVID-19 / Disease (COVID-19 only), tissue and cell type | FAT3 LAMA2 LAMB1 LAMC1 SVEP1 THBS2 PLXDC2 SLIT3 LRP1 LTBP2 DKK3 | 1.57e-12 | 198 | 105 | 11 | 3ec01a55ade5e1627258cc3cfebb2c3207a4cb43 |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | PCSK5 ADAMTSL1 FAT3 LAMA2 LAMB1 ECM1 SVEP1 THBS2 JAG1 LTBP2 DKK3 | 1.57e-12 | 198 | 105 | 11 | bd11b0e9e80449aab979a02c1023e0638c431c7c |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_peribronchial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COMP LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LTBP2 DKK3 | 1.66e-12 | 199 | 105 | 11 | e1f1950d6f840485e263b83dc81b98910be3ae7a |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts-Adventitial_fibroblasts_L.2.1.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | PCSK5 COMP LAMA2 LAMC1 ECM1 SVEP1 THBS2 THBS4 FBLN2 LRP1 LTBP2 | 1.66e-12 | 199 | 105 | 11 | 1fd7bbb8727607e6507848602a19bc86882ef2d5 |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COMP FSTL3 EFEMP2 INSRR LAMA2 LAMB1 SVEP1 THBS2 FBLN2 LTBP2 DKK3 | 1.66e-12 | 199 | 105 | 11 | 21335475bbfbad8a6943b8076a6c1c67f3eec5d3 |
| ToppCell | Biopsy_Other_PF-Mesenchymal-Myofibroblasts|Biopsy_Other_PF / Sample group, Lineage and Cell type | COMP EFEMP2 LAMA2 LAMB1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LTBP2 DKK3 | 1.76e-12 | 200 | 105 | 11 | e504570fd7eec1524c401b1cfa9d10822d80d994 |
| ToppCell | Bronchial-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FSTL3 EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LTBP2 | 1.76e-12 | 200 | 105 | 11 | 5ea12e17f50fefbf5534e487af3392b2fa2d13ad |
| ToppCell | 343B-Fibroblasts|343B / Donor, Lineage, Cell class and subclass (all cells) | FSTL3 EFEMP2 LAMA2 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LRP1 LTBP2 DKK3 | 1.76e-12 | 200 | 105 | 11 | 376c1a77031e090be96948b47c78ac0d393f5775 |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | FSTL3 LAMA2 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LRP1 LTBP2 | 1.76e-12 | 200 | 105 | 11 | db6281b5d4032116310db379d9175d790994c99c |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | EFEMP2 LAMA2 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LRP1 LTBP2 | 1.76e-12 | 200 | 105 | 11 | cfea2f9d85646c9b722150551ff2e8fc4f6cc98a |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FSTL3 EFEMP2 LAMA2 LAMB1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LTBP2 DKK3 | 1.76e-12 | 200 | 105 | 11 | 6e3d1ae0ef84d3075afa40129a41169996462672 |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | FSTL3 LAMA2 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LRP1 LTBP2 | 1.76e-12 | 200 | 105 | 11 | 10f0c20ba7c71d9e2e177597f85b41cb40f0d878 |
| ToppCell | Tracheal-10x3prime_v2-Stromal|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | FSTL3 LAMA2 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LRP1 DKK3 | 1.76e-12 | 200 | 105 | 11 | f74b9b0e27afedd589e828d30194e8417029817a |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | FSTL3 EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LTBP2 | 1.76e-12 | 200 | 105 | 11 | 6316c288022719b9e6c4332c5cb9041e1188d0e8 |
| ToppCell | Parenchymal-10x3prime_v2-Stromal-Fibroblastic-Fibro_peribronchial|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | COMP LAMA2 LAMB1 LAMC1 ECM1 SVEP1 FBLN2 PLXDC2 LRP1 LTBP2 DKK3 | 1.76e-12 | 200 | 105 | 11 | efdf7066b7dd43e35dbc0d2719b75f250cf54af2 |
| ToppCell | 5'-Adult-Distal_Rectal-Mesenchymal-fibroblastic-Transitional_Stromal_3_(C3+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | FSTL3 LAMA2 LAMC1 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LRP1 LTBP2 | 1.76e-12 | 200 | 105 | 11 | a2bb67a06757f19be3f56f8cb5bb7e2affa5f4ed |
| ToppCell | Fibroblast|World / shred by cell class for parenchyma | FSTL3 EFEMP2 LAMA2 ECM1 SVEP1 THBS2 FBLN2 PLXDC2 SLIT3 LRP1 LTBP2 | 1.76e-12 | 200 | 105 | 11 | dec9ce1bc2571197003596f32e5f742ede72aa79 |
| ToppCell | Parenchymal-10x5prime-Stromal-Fibroblastic-Fibro_myofibroblast|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | COMP EFEMP2 LAMA2 LAMB1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LTBP2 DKK3 | 1.76e-12 | 200 | 105 | 11 | 54806080b5e97859ee6a4a9b4f19e22021c218f5 |
| ToppCell | Tracheal-10x5prime-Stromal|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | PCSK5 FSTL3 EFEMP2 LAMA2 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LRP1 LTBP2 | 1.76e-12 | 200 | 105 | 11 | 920e6036c0a9c0089d0d898673daf9dd9d7279fc |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | EFEMP2 LAMA2 LAMB1 LAMC1 ECM1 SVEP1 THBS2 FBLN2 SLIT3 LRP1 LTBP2 | 1.76e-12 | 200 | 105 | 11 | 5a87bb8eb1c6bd2fbc357e1528e15ba1c0051438 |
| ToppCell | metastatic_Brain-Fibroblasts-Myofibroblasts|metastatic_Brain / Location, Cell class and cell subclass | 1.79e-11 | 181 | 105 | 10 | bd0b5f74f9c81ec0f1592710774a4fdf33d9d5a9 | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-11 | 190 | 105 | 10 | bd0d68dc1b6f388190a6ba8a83b011619abe2bdd | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-11 | 190 | 105 | 10 | e275de94468872e70cf305b3b450823d4c9c5e3f | |
| ToppCell | droplet-Mammary_Gland-nan-3m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.90e-11 | 190 | 105 | 10 | ee2f4a55d2fd18b83e55399b5b5697a15a2d2e70 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-Cd34+|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-11 | 191 | 105 | 10 | 6cab0334f76c973880bd8d1638856f2f6e4a249a | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-11 | 191 | 105 | 10 | 850c6fff6dc795431ef534fdaa41e4ad50f7367a | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal-stromal_cell|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-11 | 191 | 105 | 10 | a57cf0519d749febc0b69fe0b098b7ba53d63258 | |
| ToppCell | droplet-Fat-Gat-18m-Mesenchymal-mesenchymal_stem_cell_of_adipose|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-11 | 191 | 105 | 10 | 8b2b00202d3c98bccbae1b4a23713892fad0ff23 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Mesenchymal|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.05e-11 | 191 | 105 | 10 | 19c67a812b8ce97472d316acd15aeefe8736000d | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-mLN_Stroma_(FMO2+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.05e-11 | 191 | 105 | 10 | 4e4488380379ed29d7898bae4e24221e7c67eb9d | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 192 | 105 | 10 | 671d4e1eee5aba03c43dbc98f4b51ce42b3df5d5 | |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal-mesenchymal_progenitor|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 192 | 105 | 10 | 0b3161ce3add9f7457f4cfa5749dbb6501e3ad36 | |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-Adventitial_Fibroblast|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 LAMC1 SVEP1 FBLN2 PLXDC2 SLIT3 LRP1 LTBP3 | 3.21e-11 | 192 | 105 | 10 | a2c31390da4962bda9a936470b0b68fa1f5d47d1 |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal-mesenchymal_stem_cell_of_adipose|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 192 | 105 | 10 | 61c7ec6171c519b2f3e9ce623669162c0c6ba9f5 | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 ECM1 SVEP1 FBLN2 FBN2 PLXDC2 PLA1A SLIT3 | 3.21e-11 | 192 | 105 | 10 | 8937a59f6bbe07f671bdabbd3707dc9c17a14cd9 |
| ToppCell | facs-Lung-nan-3m-Mesenchymal-adventitial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 LAMC1 SVEP1 FBLN2 PLXDC2 SLIT3 LRP1 LTBP3 | 3.21e-11 | 192 | 105 | 10 | eeab1cef7c36ae824381952c5b2c982368c379fd |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-11 | 192 | 105 | 10 | fc940f91ff8e051631dbf25e6e8d73cf8337eccb | |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 ECM1 SVEP1 FBLN2 FBN2 PLXDC2 PLA1A SLIT3 | 3.21e-11 | 192 | 105 | 10 | e4a7f2673f801b008ca67291db2fb2b9fd2955b8 |
| ToppCell | facs-Pancreas-Exocrine-3m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 ECM1 SVEP1 FBLN2 FBN2 PLXDC2 PLA1A SLIT3 | 3.21e-11 | 192 | 105 | 10 | ac1477433704573f95111eee6263b93668d2845e |
| ToppCell | facs-BAT-Fat-24m-Mesenchymal|BAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 192 | 105 | 10 | 24d682e3247a73d349e7776b9e564b6b57f4cb13 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-adventitial_fibroblast|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-11 | 192 | 105 | 10 | 32acd89617934016cd135d2cc797e8e79ae1b37f | |
| ToppCell | facs-Trachea-24m-Mesenchymal-fibroblast-fibroblast_of_trachea|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 3.21e-11 | 192 | 105 | 10 | 7a2e79490e4f7058bb76b46c45b5df9f729e3146 | |
| ToppCell | facs-Heart-LV-3m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.21e-11 | 192 | 105 | 10 | 840a34c1b82d218be999ab5e1bcafd6370d7a4b1 | |
| ToppCell | 3'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2-Peribronchial_fibroblasts-Peribronchial_fibroblasts_L.2.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.21e-11 | 192 | 105 | 10 | c5f8e766453f87847b740d6988c524b3d0ef3765 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast_of_cardiac_tissue|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-11 | 193 | 105 | 10 | 0a665531d581d4e3941e29d3f95569da8f166447 | |
| ToppCell | droplet-Lung-30m-Mesenchymal-fibroblast-adventitial_fibroblast|30m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | ADAMTSL1 LAMA2 LAMB1 SVEP1 ADH7 THBS2 FBLN2 PLXDC2 SLIT3 DKK3 | 3.38e-11 | 193 | 105 | 10 | 9d0b966d13cbce97beb43de6dc77f006c363a181 |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-11 | 193 | 105 | 10 | f95b95c58a6edb8a03dd15ae166f47f9f33d8bd6 | |
| ToppCell | LA|World / Chamber and Cluster_Paper | 3.38e-11 | 193 | 105 | 10 | d4bf89437216baf489ea0239136dcedf3b6714af | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-11 | 193 | 105 | 10 | 85faf6c5ce4769615a4eca036e2ba307e176bb52 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-11 | 193 | 105 | 10 | 24ce1f37cca655415410d2403a52d1ebb3332280 | |
| ToppCell | facs-MAT-Fat-3m-Mesenchymal|MAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.38e-11 | 193 | 105 | 10 | 110a7d2ba7d066c2be38be98b643b76c520dd980 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Mesenchymal|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.56e-11 | 194 | 105 | 10 | 2d0cff9dc538a14518741e2a96d9d78442c81a72 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | LAMA2 LAMB1 LAMC1 SVEP1 THBS2 FBLN2 PLXDC2 LRP1 LTBP2 NOTCH2 | 3.56e-11 | 194 | 105 | 10 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 |
| ToppCell | ASK428-Mesenchymal|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.74e-11 | 195 | 105 | 10 | 2b156163975d9a3d3fda1402acd9831d0fdc9e25 | |
| ToppCell | ASK428-Mesenchymal-Fibroblast|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 3.74e-11 | 195 | 105 | 10 | c269c0d894a0f55da6495b59d4b9abb9f68df684 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 3.94e-11 | 196 | 105 | 10 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Mesenchymal-chondrocyte-like|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.94e-11 | 196 | 105 | 10 | fcb275746bf51269ed8ba4cf93edb054a45f1ccd | |
| ToppCell | IPF-Stromal-Myofibroblast|IPF / Disease state, Lineage and Cell class | 3.94e-11 | 196 | 105 | 10 | 2d0a48e49b3b37bb66e33e74c52915911e1f8a74 | |
| ToppCell | 5'-Parenchyma_lung-Mesenchymal-Fibroblastic-fibroblastic_type_2|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.94e-11 | 196 | 105 | 10 | 42e9828222a9663525d571633e8a454c30bfa7f8 | |
| ToppCell | facs-Lung-nan|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 LAMB2 LAMC1 FBLN2 PLXDC2 SLIT3 LRP1 LTBP3 | 3.94e-11 | 196 | 105 | 10 | b05f77f3990b662682ffeaf0e4c2fb190e0a6e65 |
| ToppCell | facs-Lung-nan-3m|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | ADAMTSL1 LAMA2 LAMB1 LAMB2 LAMC1 FBLN2 PLXDC2 SLIT3 LRP1 LTBP3 | 3.94e-11 | 196 | 105 | 10 | 787c6cd92035e0b1108c2c086c42a229016e476b |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 4.14e-11 | 197 | 105 | 10 | 2cb1f557ce1400398975de94638126b4522567f3 | |
| ToppCell | facs-Trachea-nan-3m-Mesenchymal-fibroblast|Trachea / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 4.35e-11 | 198 | 105 | 10 | 0dc7d59a07428a7b7e8bdc81f0e2417dd4ce3cf2 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.57e-11 | 199 | 105 | 10 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1-Adventitial_fibroblasts|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-11 | 199 | 105 | 10 | 9672230aa0bc6a7289050c955f5154ca183a5159 | |
| ToppCell | 3'-Broncho-tracheal-Mesenchymal-Fibroblastic-fibroblastic_type_1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 4.57e-11 | 199 | 105 | 10 | e18abe678da293bd01fae55e2f9ab6fdd643d02d | |
| ToppCell | Fibroblasts-CD34+_Fibroblasts|World / Immune cells in Rheumatoid Arthritis Joint Synovial Tissues | 4.57e-11 | 199 | 105 | 10 | 13ff7409e200a0b46cdb7924d15ef33639693622 | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 4.57e-11 | 199 | 105 | 10 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | cellseq-Mesenchymal-Fibroblastic|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 4.80e-11 | 200 | 105 | 10 | 8978867bf69c830b1e48cac2ad6b512dbe60f149 | |
| Computational | Adhesion molecules. | COMP EFEMP2 LAMA2 LAMA5 LAMB1 LAMB2 LAMB3 LAMC2 THBS2 THBS4 FBN2 ADGRE1 | 8.99e-11 | 141 | 70 | 12 | MODULE_122 |
| Computational | Metal / Ca ion binding. | COMP EFEMP2 ADH7 THBS2 THBS4 FBLN2 FBN2 SLIT3 LRP1 LTBP2 ADGRE1 | 7.98e-10 | 133 | 70 | 11 | MODULE_324 |
| Computational | Placenta genes. | ERBB3 ADAM19 FSTL3 LAMA5 LAMB2 DLK1 ECM1 STAB1 FBLN2 FBN2 JAG1 LRP1 LTBP2 NOTCH3 | 1.31e-06 | 463 | 70 | 14 | MODULE_38 |
| Computational | DRG (dorsal root ganglia) genes. | ERBB3 FSTL3 LAMA5 LAMB1 LAMB2 AHDC1 STAB1 THBS2 FBLN2 LRP1 LTBP2 NOTCH3 | 5.94e-06 | 384 | 70 | 12 | MODULE_2 |
| Computational | ECM and collagens. | 1.41e-05 | 225 | 70 | 9 | MODULE_47 | |
| Computational | Ovary genes. | ADAM19 FSTL3 LAMB1 LAMB2 DLK1 AHDC1 STAB1 THBS2 LRP1 LTBP2 NOTCH3 | 2.30e-05 | 368 | 70 | 11 | MODULE_1 |
| Computational | Neighborhood of IGFBP1 | 5.02e-04 | 57 | 70 | 4 | CAR_IGFBP1 | |
| Computational | Neighborhood of CDH11 | 5.49e-04 | 25 | 70 | 3 | GNF2_CDH11 | |
| Computational | Heparin binding. | 7.71e-04 | 28 | 70 | 3 | MODULE_385 | |
| Computational | Neighborhood of EGFR | 1.15e-03 | 32 | 70 | 3 | GNF2_EGFR | |
| Computational | Neighborhood of HPX | 1.28e-03 | 73 | 70 | 4 | CAR_HPX | |
| Computational | Trachea genes. | 1.41e-03 | 415 | 70 | 9 | MODULE_6 | |
| Computational | Neighborhood of PTX3 | 1.62e-03 | 36 | 70 | 3 | GNF2_PTX3 | |
| Computational | Spinal cord (neuro-development) genes. | 2.26e-03 | 360 | 70 | 8 | MODULE_12 | |
| Drug | AC1L1G72 | 2.17e-17 | 11 | 103 | 8 | CID000003553 | |
| Drug | LG 5 | 1.43e-13 | 60 | 103 | 10 | CID011840957 | |
| Drug | AC1L1B58 | 5.28e-13 | 29 | 103 | 8 | CID000001288 | |
| Drug | 2-amino-5-methylpyridine | 1.96e-12 | 77 | 103 | 10 | CID000015348 | |
| Drug | kalinin | 2.97e-12 | 55 | 103 | 9 | CID000032518 | |
| Drug | Calcort | 5.81e-12 | 38 | 103 | 8 | CID000026709 | |
| Drug | Sikvav | 1.02e-11 | 24 | 103 | 7 | CID005487517 | |
| Drug | dysprosium | 4.81e-11 | 74 | 103 | 9 | CID000023912 | |
| Drug | NSC 714187 | 1.72e-10 | 85 | 103 | 9 | CID005288693 | |
| Drug | CC270 | 2.44e-10 | 59 | 103 | 8 | CID006918852 | |
| Drug | BM165 | 7.77e-10 | 11 | 103 | 5 | CID003352881 | |
| Drug | Rgd Peptide | LAMB4 ADAM15 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 THBS2 THBS4 FBN2 ADGRE1 FBN3 | 8.94e-10 | 239 | 103 | 12 | CID000104802 |
| Drug | YIGSR | 2.66e-09 | 79 | 103 | 8 | CID000123977 | |
| Drug | 2-[(1R,2R,3S,4R,5R,6S)-2-[(2R,5S)-3-[(3S,4S,5R,6S)-4,5-dihydroxy-3-(methylamino)-6-methylol-tetrahydropyran-2-yl]-4-formyl-4-hydroxy-5-methylol-tetrahydrofuran-2-yl]oxy-5-guanidino-3,4,6-trihydroxy-cyclohexyl]guanidine | 3.97e-09 | 83 | 103 | 8 | CID011968896 | |
| Drug | 2,4-diaminopyrimidine | 4.69e-09 | 54 | 103 | 7 | CID000067431 | |
| Drug | 1,2-dimethylhydrazine | 5.28e-09 | 86 | 103 | 8 | CID000001322 | |
| Drug | H-9 dihydrochloride | 7.60e-09 | 90 | 103 | 8 | CID000003544 | |
| Drug | Ikvav | 1.82e-08 | 38 | 103 | 6 | CID000131343 | |
| Drug | ALT-711 | 3.30e-08 | 21 | 103 | 5 | CID000216304 | |
| Drug | quercetin | MPO LAMB4 ERBB3 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 KEAP1 STAT6 IL9 HDC | 3.71e-08 | 482 | 103 | 14 | CID005280343 |
| Drug | chondroitin sulfate | COMP KRT83 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 THBS2 THBS4 FBLN2 ADAMTS7 AGRN PLXNB3 | 4.66e-08 | 413 | 103 | 13 | CID000024766 |
| Drug | LMWH | MPO LAMB4 ERBB3 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 THBS2 THBS4 FBLN2 LRP1 LRP2 AGRN | 4.78e-08 | 663 | 103 | 16 | CID000000772 |
| Drug | Grgds | 9.88e-08 | 83 | 103 | 7 | CID000123811 | |
| Drug | pyrachlostrobin | EFEMP2 LAMA5 LAMB2 LAMC1 DLK1 ECM1 SVEP1 STAT6 STAB1 THBS2 FBLN2 LRP2 LRP5 LTBP2 LTBP3 NOTCH2 NOTCH3 | 1.32e-07 | 811 | 103 | 17 | ctd:C513428 |
| Drug | AC1L9INI | 2.75e-07 | 59 | 103 | 6 | CID000445839 | |
| Drug | AC1O0B8G | 3.16e-07 | 262 | 103 | 10 | CID000091605 | |
| Drug | I-Q-S | 5.56e-07 | 156 | 103 | 8 | CID000003540 | |
| Drug | isocycloheximide | LAMB4 ERBB3 TNFRSF9 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 LRP1B STAT6 GJD3 LRP1 LRP2 IL9 HDC | 6.15e-07 | 905 | 103 | 17 | CID000002900 |
| Drug | B-Ms | 8.73e-07 | 114 | 103 | 7 | CID000445091 | |
| Drug | DB04780 | 1.07e-06 | 170 | 103 | 8 | CID005459389 | |
| Drug | quinaprilat | 1.44e-06 | 43 | 103 | 5 | CID000107994 | |
| Drug | cobalt-60 | MPO LAMB4 ENPP1 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 AGRN | 1.58e-06 | 390 | 103 | 11 | CID000061492 |
| Drug | MRK 003 | ERBB3 TNFRSF9 ADAM15 IER5 ECM1 ST14 STAB1 ADAMTS7 LTBP2 ADGRE1 MEGF11 NOTCH2 NOTCH3 NOTCH4 HDC | 1.65e-06 | 760 | 103 | 15 | ctd:C523799 |
| Drug | maltos | LAMB4 TNFRSF9 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 LGALS12 STAT6 | 1.70e-06 | 393 | 103 | 11 | CID000000294 |
| Drug | Tolmetin sodium salt dihydrate [64490-92-2]; Up 200; 12.6uM; HL60; HT_HG-U133A | 3.33e-06 | 198 | 103 | 8 | 3009_UP | |
| Drug | Florfenicol [73231-34-2]; Up 200; 11.2uM; MCF7; HT_HG-U133A | 3.33e-06 | 198 | 103 | 8 | 6460_UP | |
| Drug | Pinacidil [85371-64-8]; Up 200; 16.4uM; HL60; HT_HG-U133A | 3.46e-06 | 199 | 103 | 8 | 2406_UP | |
| Drug | Flucytosine [2022-85-7]; Up 200; 31uM; MCF7; HT_HG-U133A | 3.59e-06 | 200 | 103 | 8 | 6450_UP | |
| Drug | Reidispongiolide C | 5.03e-06 | 279 | 103 | 9 | CID005289285 | |
| Drug | Betamethasone-d5 | MPO LAMB4 ENPP1 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 LGALS12 DLK1 STAT6 STAB1 AFM LRP1 FBN3 IL9 HDC | 8.03e-06 | 1340 | 103 | 19 | CID000003003 |
| Drug | Rgds Peptide | 8.76e-06 | 106 | 103 | 6 | CID000107775 | |
| Drug | colchine | 9.49e-06 | 383 | 103 | 10 | CID000002833 | |
| Drug | Gdrgdsp | 1.03e-05 | 109 | 103 | 6 | CID000115346 | |
| Drug | AC1L1C2F | 1.08e-05 | 110 | 103 | 6 | CID000001711 | |
| Drug | 1-(5-isoquinolinesulfonyl)-2-methylpiperazine | 1.30e-05 | 314 | 103 | 9 | CID000003542 | |
| Drug | sulfate | MPO HGFAC LAMB4 ERBB3 COMP FSTL3 ENPP1 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 ST14 THBS2 THBS4 AGRN | 1.83e-05 | 1292 | 103 | 18 | CID000001117 |
| Drug | A0395 | 2.31e-05 | 75 | 103 | 5 | CID009906466 | |
| Drug | bu-b | 2.62e-05 | 77 | 103 | 5 | CID000351065 | |
| Drug | Methylprednisolone | 2.68e-05 | 129 | 103 | 6 | ctd:D008775 | |
| Drug | Guaifenesin [93-14-1]; Up 200; 20.2uM; PC3; HT_HG-U133A | 3.00e-05 | 195 | 103 | 7 | 4549_UP | |
| Drug | Flunixin meglumine [42461-84-7]; Up 200; 8.2uM; HL60; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 2552_UP | |
| Drug | Bicuculline (+) [485-49-4]; Down 200; 10.8uM; MCF7; HT_HG-U133A | 3.31e-05 | 198 | 103 | 7 | 4397_DN | |
| Drug | lead stearate | 4.00e-05 | 84 | 103 | 5 | CID000061258 | |
| Drug | Mifepristone | ERBB3 COMP FSTL3 ADAM15 LAMA2 LAMA5 LAMC2 SVEP1 PLXDC2 SLIT3 NOTCH4 | 4.17e-05 | 553 | 103 | 11 | ctd:D015735 |
| Drug | trypanothione disulfide | 4.25e-05 | 140 | 103 | 6 | CID000115098 | |
| Drug | poly-N-acetyllactosamine | 5.00e-05 | 88 | 103 | 5 | CID000119547 | |
| Drug | 1-alpha-25-dihydroxycholecalciferol | PCSK5 LAMB4 ERBB3 ADAM19 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 NELL2 HDC AGAP3 | 5.99e-05 | 909 | 103 | 14 | CID000002524 |
| Drug | funiferine N-oxide | 7.16e-05 | 49 | 103 | 4 | CID000191631 | |
| Drug | BMS-186282 | 7.21e-05 | 95 | 103 | 5 | CID000002416 | |
| Drug | Verteporfin [129497-78-5]; Down 200; 2.8uM; MCF7; HT_HG-U133A | 7.50e-05 | 155 | 103 | 6 | 6817_DN | |
| Drug | probucol | 9.57e-05 | 162 | 103 | 6 | CID000004912 | |
| Drug | desmosine | 9.75e-05 | 53 | 103 | 4 | CID000025435 | |
| Drug | AC1L1EPA | 1.21e-04 | 4 | 103 | 2 | CID000028140 | |
| Drug | gamma-secretase inhibitor I | 1.21e-04 | 4 | 103 | 2 | CID011754711 | |
| Drug | dithiotreitol | 1.47e-04 | 430 | 103 | 9 | CID000019001 | |
| Drug | genistein | MPO LAMB4 ERBB3 COMP ADAM15 LAMA1 LAMA2 LAMA5 LAMB1 LAMB2 LAMC1 LAMC2 TYK2 NELL2 ADAMTS7 | 1.48e-04 | 1117 | 103 | 15 | CID005280961 |
| Drug | 1-piperidinocyclohexanecarbonitrile | 1.92e-04 | 25 | 103 | 3 | CID000062529 | |
| Drug | hyaluronan | 1.95e-04 | 263 | 103 | 7 | CID000024759 | |
| Drug | PHA-00851261E [724719-49-7]; Down 200; 10uM; PC3; HT_HG-U133A | 2.41e-04 | 192 | 103 | 6 | 4330_DN | |
| Drug | Testosterone propionate [57-85-2]; Up 200; 11.6uM; PC3; HT_HG-U133A | 2.48e-04 | 193 | 103 | 6 | 4676_UP | |
| Drug | Omeprazole [73590-58-6]; Up 200; 11.6uM; MCF7; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 2828_UP | |
| Drug | 2-propylpentanoic acid; Up 200; 200uM; HL60; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 6173_UP | |
| Drug | Hydroxyzine dihydrochloride [2192-20-3]; Down 200; 9uM; PC3; HT_HG-U133A | 2.55e-04 | 194 | 103 | 6 | 6660_DN | |
| Drug | NU1025; Up 200; 100uM; MCF7; HG-U133A | 2.55e-04 | 194 | 103 | 6 | 608_UP | |
| Drug | Rapamycin; Down 200; 0.1uM; HL60; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 6180_DN | |
| Drug | Heliotrine [303-33-3]; Up 200; 12.8uM; MCF7; HT_HG-U133A | 2.62e-04 | 195 | 103 | 6 | 6035_UP | |
| Drug | glycidol | 2.67e-04 | 466 | 103 | 9 | ctd:C004312 | |
| Drug | Cefsulodin sodium salt [52152-93-9]; Up 200; 7.2uM; HL60; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 2988_UP | |
| Drug | Ethosuximide [77-67-8]; Up 200; 28.4uM; MCF7; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 2280_UP | |
| Drug | Amikacin hydrate [37517-28-5]; Up 200; 6.6uM; PC3; HT_HG-U133A | 2.70e-04 | 196 | 103 | 6 | 6715_UP | |
| Drug | 17-AAG; Down 200; 1uM; MCF7; HG-U133A | 2.77e-04 | 197 | 103 | 6 | 381_DN | |
| Drug | Indapamide [26807-65-8]; Up 200; 10.6uM; HL60; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 2361_UP | |
| Drug | ICI 182,780; Up 200; 0.01uM; HL60; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 2698_UP | |
| Drug | Tomatidine [77-59-8]; Up 200; 9.6uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 2746_UP | |
| Drug | Hesperidin [520-26-3]; Up 200; 6.6uM; PC3; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 6714_UP | |
| Drug | Serotonin hydrochloride [153-98-0]; Up 200; 18.8uM; MCF7; HT_HG-U133A | 2.77e-04 | 197 | 103 | 6 | 5633_UP | |
| Drug | Aztreonam [78110-38-0]; Up 200; 9.2uM; PC3; HT_HG-U133A | 2.85e-04 | 198 | 103 | 6 | 5110_UP | |
| Drug | Dimenhydrinate [523-87-5]; Down 200; 8.6uM; HL60; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 2400_DN | |
| Drug | Epiandrosterone [481-29-8]; Up 200; 13.8uM; MCF7; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 3306_UP | |
| Drug | Paromomycin sulfate [1263-89-4]; Up 200; 5.6uM; PC3; HT_HG-U133A | 2.93e-04 | 199 | 103 | 6 | 4595_UP | |
| Drug | Leucomyosuppressin | 3.00e-04 | 6 | 103 | 2 | CID000176039 | |
| Drug | dictamnine | 3.00e-04 | 6 | 103 | 2 | CID000068085 | |
| Drug | vgBE | 3.00e-04 | 6 | 103 | 2 | CID000193461 | |
| Drug | Tnrnflrfamide | 3.00e-04 | 6 | 103 | 2 | CID003081636 | |
| Drug | 3-Acetylcoumarin [3949-36-8]; Up 200; 21.2uM; HL60; HT_HG-U133A | 3.01e-04 | 200 | 103 | 6 | 3044_UP | |
| Drug | monatepil | 3.02e-04 | 29 | 103 | 3 | CID000060810 | |
| Drug | 2,3-pentanedione | 3.03e-04 | 129 | 103 | 5 | ctd:C013186 | |
| Drug | Smoke | MPO ERBB3 TNFRSF9 ADAM19 LAMA1 LAMA5 ECM1 ST14 SVEP1 ADH7 THBS2 PLXDC2 NOTCH3 | 3.11e-04 | 937 | 103 | 13 | ctd:D012906 |
| Drug | dl-Lysine | 3.53e-04 | 290 | 103 | 7 | CID000000866 | |
| Disease | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement | 1.51e-07 | 4 | 100 | 3 | EFO_0803113 | |
| Disease | cortical thickness | ERBB3 FAT3 LAMA1 LAMA2 LAMC1 LGALS12 KIAA1614 STAB1 NELL2 FBN2 PLXDC2 ADAMTS7 JAG1 LRP1 AGAP3 | 5.11e-06 | 1113 | 100 | 15 | EFO_0004840 |
| Disease | retinal detachment, retinal break | 6.00e-06 | 35 | 100 | 4 | EFO_0005773, EFO_0010698 | |
| Disease | age of onset of asthma | 7.47e-06 | 79 | 100 | 5 | OBA_2001001 | |
| Disease | Bladder Neoplasm | 8.47e-06 | 140 | 100 | 6 | C0005695 | |
| Disease | Malignant neoplasm of urinary bladder | 8.82e-06 | 141 | 100 | 6 | C0005684 | |
| Disease | Hepatic ductular hypoplasia | 1.14e-05 | 2 | 100 | 2 | C2930797 | |
| Disease | Alagille syndrome (is_implicated_in) | 1.14e-05 | 2 | 100 | 2 | DOID:9245 (is_implicated_in) | |
| Disease | Alagille Syndrome 2 | 1.14e-05 | 2 | 100 | 2 | C1857761 | |
| Disease | Alagille Syndrome 1 | 1.14e-05 | 2 | 100 | 2 | C1956125 | |
| Disease | laminin subunit gamma-2 measurement | 1.14e-05 | 2 | 100 | 2 | EFO_0801756 | |
| Disease | Alagille Syndrome | 1.14e-05 | 2 | 100 | 2 | C0085280 | |
| Disease | Arteriohepatic dysplasia | 1.14e-05 | 2 | 100 | 2 | cv:C0085280 | |
| Disease | cortical surface area measurement | ERBB3 ADAMTSL1 ZAN ADAM15 FAT3 LAMA2 LAMC1 LGALS12 KIAA1614 SVEP1 FBN2 PLXDC2 ADAMTS7 JAG1 FBN3 AGAP3 | 1.15e-05 | 1345 | 100 | 16 | EFO_0010736 |
| Disease | caffeine measurement | 1.67e-05 | 15 | 100 | 3 | EFO_0021177 | |
| Disease | Colorectal Carcinoma | MPO TNFRSF9 ADAM19 LAMA1 LAMB3 LAMC1 FBLN2 FBN2 LRP1 LRP2 HDC | 2.66e-05 | 702 | 100 | 11 | C0009402 |
| Disease | Junctional epidermolysis bullosa | 3.40e-05 | 3 | 100 | 2 | cv:C0079301 | |
| Disease | Junctional epidermolysis bullosa gravis of Herlitz | 3.40e-05 | 3 | 100 | 2 | cv:C0079683 | |
| Disease | junctional epidermolysis bullosa Herlitz type (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:0060737 (implicated_via_orthology) | |
| Disease | connective tissue disease (implicated_via_orthology) | 3.40e-05 | 3 | 100 | 2 | DOID:65 (implicated_via_orthology) | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL 1B, SEVERE | 3.40e-05 | 3 | 100 | 2 | 226700 | |
| Disease | systemic lupus erythematosus, COVID-19 | 4.58e-05 | 58 | 100 | 4 | MONDO_0007915, MONDO_0100096 | |
| Disease | Prostatic Neoplasms | 4.69e-05 | 616 | 100 | 10 | C0033578 | |
| Disease | Malignant neoplasm of prostate | 4.69e-05 | 616 | 100 | 10 | C0376358 | |
| Disease | Malignant neoplasm of skin | 4.90e-05 | 59 | 100 | 4 | C0007114 | |
| Disease | Skin Neoplasms | 4.90e-05 | 59 | 100 | 4 | C0037286 | |
| Disease | Herlitz Disease | 6.79e-05 | 4 | 100 | 2 | C0079683 | |
| Disease | Epidermolysis Bullosa Progressiva | 6.79e-05 | 4 | 100 | 2 | C0079297 | |
| Disease | laminin measurement | 6.79e-05 | 4 | 100 | 2 | EFO_0020528 | |
| Disease | pulse pressure measurement | HGFAC FSTL3 FAT3 LAMA5 AHDC1 SVEP1 THBS2 FBN2 PLXDC2 JAG1 SLIT3 LRP1 LTBP2 LTBP3 NOTCH3 | 6.89e-05 | 1392 | 100 | 15 | EFO_0005763 |
| Disease | Carcinoma, Pancreatic Ductal | 7.26e-05 | 24 | 100 | 3 | C0887833 | |
| Disease | response to angiotensin-converting enzyme inhibitor, response to angiotensin receptor blocker, angioedema | 9.28e-05 | 26 | 100 | 3 | EFO_0005325, EFO_0005532, EFO_0010735 | |
| Disease | Adult junctional epidermolysis bullosa (disorder) | 1.13e-04 | 5 | 100 | 2 | C0268374 | |
| Disease | EPIDERMOLYSIS BULLOSA, JUNCTIONAL, LOCALISATA VARIANT (disorder) | 1.13e-04 | 5 | 100 | 2 | C2608084 | |
| Disease | Keratosis Blennorrhagica | 1.13e-04 | 5 | 100 | 2 | C0022594 | |
| Disease | Keratosis | 1.13e-04 | 5 | 100 | 2 | C0022593 | |
| Disease | response to silica exposure, pneumoconiosis | 1.13e-04 | 5 | 100 | 2 | EFO_0005853, MONDO_0015926 | |
| Disease | Keratoma | 1.13e-04 | 5 | 100 | 2 | C0086501 | |
| Disease | junctional epidermolysis bullosa non-Herlitz type (implicated_via_orthology) | 1.13e-04 | 5 | 100 | 2 | DOID:0060738 (implicated_via_orthology) | |
| Disease | suicidal ideation | 1.29e-04 | 29 | 100 | 3 | EFO_0004320 | |
| Disease | Junctional Epidermolysis Bullosa | 1.69e-04 | 6 | 100 | 2 | C0079301 | |
| Disease | intestinal cancer (implicated_via_orthology) | 1.74e-04 | 32 | 100 | 3 | DOID:10155 (implicated_via_orthology) | |
| Disease | junctional epidermolysis bullosa (is_implicated_in) | 2.36e-04 | 7 | 100 | 2 | DOID:3209 (is_implicated_in) | |
| Disease | adenocarcinoma (implicated_via_orthology) | 2.36e-04 | 7 | 100 | 2 | DOID:299 (implicated_via_orthology) | |
| Disease | cholesteryl ester 16:2 measurement | 2.36e-04 | 7 | 100 | 2 | EFO_0021435 | |
| Disease | central nervous system cancer (implicated_via_orthology) | 2.36e-04 | 7 | 100 | 2 | DOID:3620 (implicated_via_orthology) | |
| Disease | Stevens-Johnson syndrome, toxic epidermal necrolysis, response to cold medicine | 2.70e-04 | 37 | 100 | 3 | EFO_0004276, EFO_0004775, EFO_0006997 | |
| Disease | bipolar II disorder | 3.14e-04 | 8 | 100 | 2 | EFO_0009964 | |
| Disease | corpus callosum anterior volume measurement | 3.16e-04 | 39 | 100 | 3 | EFO_0010295 | |
| Disease | psoriasis | 3.42e-04 | 273 | 100 | 6 | EFO_0000676 | |
| Disease | systemic lupus erythematosus | 3.86e-04 | 799 | 100 | 10 | MONDO_0007915 | |
| Disease | Abnormality of refraction | 4.76e-04 | 673 | 100 | 9 | HP_0000539 | |
| Disease | Bone Diseases | 5.03e-04 | 10 | 100 | 2 | C0005940 | |
| Disease | Glioblastoma Multiforme | 5.63e-04 | 111 | 100 | 4 | C1621958 | |
| Disease | gallbladder neoplasm | 6.13e-04 | 11 | 100 | 2 | C0016978 | |
| Disease | Marfan Syndrome | 6.13e-04 | 11 | 100 | 2 | C0024796 | |
| Disease | Malignant neoplasm of gallbladder | 6.13e-04 | 11 | 100 | 2 | C0153452 | |
| Disease | sleep quality | 7.09e-04 | 118 | 100 | 4 | EFO_0005272 | |
| Disease | non-high density lipoprotein cholesterol measurement | 7.19e-04 | 713 | 100 | 9 | EFO_0005689 | |
| Disease | Amelogenesis Imperfecta | 7.34e-04 | 12 | 100 | 2 | C0002452 | |
| Disease | congenital diaphragmatic hernia (implicated_via_orthology) | 7.34e-04 | 12 | 100 | 2 | DOID:3827 (implicated_via_orthology) | |
| Disease | Mitral valve prolapse, response to surgery | 7.34e-04 | 12 | 100 | 2 | EFO_0009951, HP_0001634 | |
| Disease | stenosing tenosynovitis | 7.34e-04 | 12 | 100 | 2 | EFO_0010822 | |
| Disease | Familial thoracic aortic aneurysm and aortic dissection | 7.82e-04 | 53 | 100 | 3 | C4707243 | |
| Disease | severe acute respiratory syndrome, COVID-19 | 8.34e-04 | 447 | 100 | 7 | EFO_0000694, MONDO_0100096 | |
| Disease | Schizophrenia | 8.36e-04 | 883 | 100 | 10 | C0036341 | |
| Disease | obesity (implicated_via_orthology) | 8.42e-04 | 215 | 100 | 5 | DOID:9970 (implicated_via_orthology) | |
| Disease | Migraine Disorders | 8.66e-04 | 13 | 100 | 2 | C0149931 | |
| Disease | gallbladder cancer (is_implicated_in) | 8.66e-04 | 13 | 100 | 2 | DOID:3121 (is_implicated_in) | |
| Disease | optic cup area measurement | 9.19e-04 | 56 | 100 | 3 | EFO_0006940 | |
| Disease | response to lithium ion | 9.19e-04 | 56 | 100 | 3 | GO_0010226 | |
| Disease | RS-warfarin measurement | 9.60e-04 | 128 | 100 | 4 | EFO_0803325 | |
| Disease | vital capacity | PCSK5 ADAMTSL1 LAMA2 SVEP1 THBS2 LRP2 LTBP2 LTBP3 DKK3 FBN3 OTOG AGAP3 | 9.72e-04 | 1236 | 100 | 12 | EFO_0004312 |
| Disease | neuroimaging measurement | ERBB3 FAT3 LAMA2 LAMC1 TYK2 NELL2 FBN2 DENND4B GJD3 JAG1 AGAP3 | 1.00e-03 | 1069 | 100 | 11 | EFO_0004346 |
| Disease | adverse effect, response to xenobiotic stimulus | 1.07e-03 | 59 | 100 | 3 | EFO_0009658, GO_0009410 | |
| Disease | Neoplasm of uncertain or unknown behavior of bladder | 1.16e-03 | 15 | 100 | 2 | C0496930 | |
| Disease | Proteinuria | 1.16e-03 | 15 | 100 | 2 | HP_0000093 | |
| Disease | Benign neoplasm of bladder | 1.16e-03 | 15 | 100 | 2 | C0154017 | |
| Disease | Carcinoma in situ of bladder | 1.16e-03 | 15 | 100 | 2 | C0154091 | |
| Disease | Ulcerative Colitis | 1.29e-03 | 63 | 100 | 3 | C0009324 | |
| Disease | Major Depressive Disorder | 1.45e-03 | 243 | 100 | 5 | C1269683 | |
| Disease | eosinophil count | ERBB3 EFEMP2 KCP IER5 SVEP1 STAT6 ADH7 JAG1 LTBP2 LTBP3 NOTCH2 NOTCH4 IL9 | 1.55e-03 | 1488 | 100 | 13 | EFO_0004842 |
| Disease | Takayasu arteritis | 1.64e-03 | 148 | 100 | 4 | EFO_1001857 | |
| Disease | Carcinoma of bladder | 1.68e-03 | 18 | 100 | 2 | C0699885 | |
| Disease | X-11470 measurement | 1.87e-03 | 19 | 100 | 2 | EFO_0021241 | |
| Disease | Hypertriglyceridemia | 1.87e-03 | 19 | 100 | 2 | EFO_0004211 | |
| Disease | renovascular hypertension (biomarker_via_orthology) | 1.87e-03 | 19 | 100 | 2 | DOID:1591 (biomarker_via_orthology) | |
| Disease | perceived unattractiveness to mosquitos measurement | 1.90e-03 | 72 | 100 | 3 | EFO_0008380 | |
| Disease | Osteoarthritis of hip | 2.08e-03 | 20 | 100 | 2 | C0029410 | |
| Disease | Lung Neoplasms | 2.12e-03 | 265 | 100 | 5 | C0024121 | |
| Disease | Malignant neoplasm of lung | 2.15e-03 | 266 | 100 | 5 | C0242379 | |
| Disease | cardiovascular system disease (is_implicated_in) | 2.29e-03 | 21 | 100 | 2 | DOID:1287 (is_implicated_in) | |
| Disease | Lung diseases | 2.39e-03 | 78 | 100 | 3 | C0024115 | |
| Disease | Glioblastoma | 2.48e-03 | 79 | 100 | 3 | C0017636 | |
| Disease | brain measurement, neuroimaging measurement | 2.71e-03 | 550 | 100 | 7 | EFO_0004346, EFO_0004464 | |
| Disease | COVID-19, mortality | 2.71e-03 | 170 | 100 | 4 | EFO_0004352, MONDO_0100096 | |
| Disease | Hodgkins lymphoma | 2.76e-03 | 82 | 100 | 3 | EFO_0000183 | |
| Disease | Giant Cell Glioblastoma | 2.95e-03 | 84 | 100 | 3 | C0334588 | |
| Disease | FEV/FEC ratio | PCSK5 ERBB3 ADAM19 LAMC2 NELL2 PLXDC2 LRP1 LTBP2 LTBP3 HDC AGAP3 | 2.98e-03 | 1228 | 100 | 11 | EFO_0004713 |
| Disease | Myasthenic Syndromes, Congenital | 2.99e-03 | 24 | 100 | 2 | C0751882 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FLPQCRECNACRNPD | 106 | P40394 | |
| RGNSFCIDCDAPNPD | 636 | Q96P47 | |
| CRHFNDSGACVPRCP | 246 | P21860 | |
| ACRCGPCFNNGVPIL | 496 | P07357 | |
| PCCDSLTCQLRPGAQ | 446 | Q13444 | |
| LRNCCNTENPPGCYR | 381 | P43652 | |
| PCCNASNCTLRPGAE | 441 | Q9H013 | |
| RCINTSPGFRCEACP | 141 | P49747 | |
| SGQCQGRDQCPEPCR | 386 | O00468 | |
| GRDQCPEPCRFNAVC | 391 | O00468 | |
| CDQAPSPCLGVQCAF | 461 | O00468 | |
| FLNRQSQCAGRCSPP | 621 | Q5TGY3 | |
| CRRACGEGFCSQPNL | 86 | Q75N90 | |
| NECESFPGVCPNGRC | 871 | Q75N90 | |
| SCLNIPGSFSCRCLP | 1296 | Q75N90 | |
| CFPACNPQNGFCEDD | 26 | P80370 | |
| LCNLQACPAGRPSFR | 586 | Q9UKP4 | |
| LRNPTVAPRCSACGC | 351 | O75808 | |
| SSQCGLQLPCCPLQA | 646 | P19113 | |
| CRQTGDFTFECNCLP | 236 | P0DPK3 | |
| CRQTGDFTFECNCLP | 236 | Q04721 | |
| QLPCQCRHGASCDPR | 186 | A6BM72 | |
| CFDNQFRCSSGRCIP | 1006 | Q9NZR2 | |
| DCPEFRCQPGRFQCG | 3351 | Q9NZR2 | |
| GFIAQCPDLNRTCPT | 216 | Q99435 | |
| CPDLNRTCPTCNDFH | 221 | Q99435 | |
| RCPACNENGLQPCQI | 231 | A6NFK2 | |
| CPPNQFSCASGRCIP | 936 | Q07954 | |
| PVCSAAQFPCARGQC | 1296 | O75197 | |
| CQACGSCIDDPRPAQ | 536 | Q5VZ46 | |
| CPPEAGDFRAQQCSA | 81 | Q8N6G6 | |
| FRCLNVPGSYQCACP | 996 | P98095 | |
| CQGPRPTDCLSCDRF | 1576 | Q92824 | |
| VAACPQFPDCASCLQ | 471 | Q9ULL4 | |
| FQVDFQCGCSLCPRP | 76 | Q96DT0 | |
| QADCIPFFRSCPACP | 306 | P05164 | |
| CAPDARCFPANGACL | 321 | Q5VY43 | |
| CDTNPVNGRAICTCP | 366 | Q9UM47 | |
| CLPNVIGQNCDRCAP | 1056 | P07942 | |
| PCLPNVQGPSCDRCA | 1066 | P55268 | |
| GCPPRCECSAQDRAV | 41 | Q96FE5 | |
| PRCNLCDCFLPGTDA | 1101 | P24043 | |
| GLPNDCQQCACPLIS | 1461 | P24043 | |
| FTRNPRDNLGCSCNP | 616 | P22413 | |
| ALCPQRFCRLGQFQC | 3546 | P98164 | |
| FPNCQACTCDPRGAL | 626 | O15230 | |
| VCACPPGFAGRLCNI | 266 | Q04756 | |
| CLGIPSDNCTRPCFS | 56 | P15248 | |
| CQDCAASCPAIARPQ | 256 | Q9UHC9 | |
| PCNSCREQCPGFLLH | 26 | O43900 | |
| CQCAPCPNNGRPTLS | 521 | P13671 | |
| LQRAFPAPAACQCHC | 1926 | Q8TD26 | |
| CAPDCSGLPARLQVC | 121 | O95633 | |
| NCESEITACFPNPCR | 4056 | Q8TDW7 | |
| AQCAPGLPEAQCAPC | 111 | Q8N144 | |
| CEPPCQNRGSCSRPQ | 191 | Q14767 | |
| GQCSSRNQCLCPPDF | 121 | Q9NS15 | |
| RNQCLCPPDFTGRFC | 126 | Q9NS15 | |
| CQDPAACRPGRCVNL | 1086 | Q9NS15 | |
| CAYNGDNCFNPMRCP | 26 | P0DP58 | |
| GCSQPEDPRACVACR | 236 | P14616 | |
| SNLNTTCPFCACPFV | 1181 | O75064 | |
| PAAVCDNARCGPATQ | 91 | Q8NEG0 | |
| GACCRFLPLQSQCPE | 11 | Q14145 | |
| CQHNTAGPNCERCAP | 281 | Q13751 | |
| PQCNQFTGQCPCREG | 491 | Q13751 | |
| GFPSCHPCPCNRFAE | 856 | A4D0S4 | |
| PCLPNVTGLACDRCA | 1051 | A4D0S4 | |
| PCDCNGRSQECYFDP | 341 | P11047 | |
| FFNLESSNPRGCTPC | 481 | P11047 | |
| CNNCPPGVTGARCEL | 481 | Q13753 | |
| TARCCDLPFPEQACC | 446 | Q16610 | |
| CEMCPAQPQPCRRGF | 251 | P35556 | |
| TCQNLEGSFRCICPP | 2031 | P35556 | |
| RSACGCRNPRCPEQA | 401 | Q3B820 | |
| RCVNLPGSFRCQCEP | 176 | O95967 | |
| QRDCQPGLCCAFQRG | 211 | Q9UBP4 | |
| ALDRCPCASGLLCQP | 261 | Q9UBP4 | |
| NFSCVSACGPRPSRC | 16 | P78385 | |
| CECAPGFAGPDCRIN | 806 | P78504 | |
| APCGSALSACPICRQ | 931 | Q96AX9 | |
| CASPCFQTCRDPRAA | 1416 | Q6ZRI0 | |
| ATPRAACCCAPQPAE | 191 | Q5VY09 | |
| SQRPNCDCPPCVFSE | 156 | Q9HBJ0 | |
| PAPQGCAVALASDRC | 1171 | P26640 | |
| GFDPQTGRCQPCNCH | 991 | O75445 | |
| DNLDAGNRQACPLCP | 111 | Q7Z2T5 | |
| QCRQRECASLCPYPA | 286 | Q6ZWJ8 | |
| FDECGPPCPRTCFNQ | 1491 | Q6ZWJ8 | |
| GDCQPCACPLTIASN | 786 | P25391 | |
| PTCLQFNRCGPCVSS | 326 | Q6UX71 | |
| QPQGACACSALRAAP | 341 | Q8NH09 | |
| PICRAVCRFPCQNGG | 3466 | Q4LDE5 | |
| CQCAPGFLGETCQFP | 51 | Q99466 | |
| CADPRACPEHATCNN | 176 | Q14246 | |
| ECRQDPSTCGPNSIC | 271 | Q14246 | |
| PSPCTCSNNIVDCRG | 281 | O75094 | |
| CRLCCPATAPQEAPA | 111 | Q96B54 | |
| GRCLDCFNPFLLSCP | 291 | Q53H76 | |
| CINLSPGFRCDACPV | 341 | P35443 | |
| CNKPNTCLCPNGFFG | 1436 | Q8N2E2 | |
| LDLSGNCPRCFNAPF | 251 | Q9NR97 | |
| NPSRERCGVPFSCCV | 176 | Q96FV3 | |
| AGSAARFSCNQPQCP | 1401 | Q13129 | |
| PLENSIPGNCCSALF | 346 | P42226 | |
| DPCPGQFTCRTGRCI | 451 | Q9Y5Y6 | |
| FCDNNRNQICSPCPP | 36 | Q07011 | |
| FSPPNENCTVCVCLA | 456 | Q96DN2 | |
| ACQECQDPNRFGPDC | 146 | Q9NY15 | |
| RCCCGQFTNQHIPPL | 6 | Q7Z4N2 | |
| ACPFRCPNCGQRFET | 531 | Q9Y2K1 | |
| RFFPGHSNCPCVCAL | 66 | B2RUY7 | |
| GARFSCPTCPFSCQQ | 1101 | P52746 | |
| CPTCPFSCQQERALR | 1106 | P52746 | |
| RSCPVDGCLSNPCFP | 546 | P35442 | |
| EPDCPCLAVCFDNGR | 221 | Q9P2L0 | |
| PDQCFCRFDLTGTCN | 1181 | O60293 | |
| NQVSCPLCDQCFPPT | 501 | Q96RL1 | |
| GDDCFSLRRCCLPQP | 541 | P29597 | |
| ACRVLADPQGPFAAC | 2546 | Q9Y493 | |
| ACEESCPFPRGNQRC | 431 | Q8TEU8 | |
| ASGAAACPLPCVCQN | 11 | Q6PJG9 |